<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.1 20050630//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Genome Biol</journal-id><journal-title>Genome Biology</journal-title><issn pub-type="ppub">1465-6906</issn><issn pub-type="epub">1465-6914</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">gb-2001-2-3-reviews3005</article-id><article-id pub-id-type="pmid">11276432</article-id><article-categories><subj-group subj-group-type="heading"><subject>Protein Family Review</subject></subj-group></article-categories><title-group><article-title>Fibroblast growth factors</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Ornitz</surname><given-names>David M</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>dornitz@molecool.wustl.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Itoh</surname><given-names>Nobuyuki</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib></contrib-group><aff id="I1"><label>1</label>Department of Molecular Biology and Pharmacology, Washington University Medical School, 660 S. Euclid Avenue, St. Louis, MO 63110, USA</aff><aff id="I2"><label>2</label>Department of Genetic Biochemistry, Kyoto University Graduate School of Pharmaceutical Sciences, Yoshida-Shimoadachi, Sakyo, Kyoto 606-8501, Japan</aff><aff>Correspondence: David M Ornitz. E-mail: dornitz@molecool.wustl.edu</aff><pub-date pub-type="ppub"><year>2001</year></pub-date><pub-date pub-type="epub"><day>9</day><month>3</month><year>2001</year></pub-date><volume>2</volume><issue>3</issue><fpage>reviews3005.1</fpage><lpage>reviews3005.12</lpage><ext-link ext-link-type="uri" xlink:href="http://genomebiology.com/2001/2/3/reviews/3005"/><copyright-statement>Copyright &#x000a9; 2001 BioMed Central Ltd</copyright-statement><abstract><p>Fibroblast growth factors (FGFs) make up a large family of polypeptide growth factors that are found in organisms ranging from nematodes to humans. In vertebrates, the 22 members of the FGF family range in molecular mass from 17 to 34 kDa and share 13-71% amino acid identity. Between vertebrate species, FGFs are highly conserved in both gene structure and amino-acid sequence. FGFs have a high affinity for heparan sulfate proteoglycans and require heparan sulfate to activate one of four cell-surface FGF receptors. During embryonic development, FGFs have diverse roles in regulating cell proliferation, migration and differentiation. In the adult organism, FGFs are homeostatic factors and function in tissue repair and response to injury. When inappropriately expressed, some FGFs can contribute to the pathogenesis of cancer. A subset of the FGF family, expressed in adult tissue, is important for neuronal signal transduction in the central and peripheral nervous systems.</p></abstract></article-meta></front><body><sec><title>Gene organization and evolutionary history</title><sec><title>Gene organization</title><p>The prototypical <italic>Fgf</italic> genes contain three coding exons (Figure <xref ref-type="fig" rid="F1">1</xref>), with exon 1 containing the initiation methionine, but several <italic>Fgf</italic> genes (for example, <italic>Fgf2</italic> and <italic>Fgf3</italic>) have additional 5' transcribed sequence that initiates from upstream CUG codons [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. The size of the coding portion of <italic>Fgf</italic> genes ranges from under 5 kb (in <italic>Fgf3</italic> and <italic>Fgf4</italic>) to over 100 kb (in <italic>Fgf12</italic>). In several <italic>Fgf</italic> subfamilies, exon 1 is subdivided into between two and four alternatively spliced sub-exons (denoted 1A-1D in the case of <italic>Fgf8</italic>). In these <italic>Fgf</italic> genes, a single initiation codon (ATG) in exon 1A is used. This gene organization is conserved in humans, mouse and zebrafish, but its functional consequences are poorly understood. Other subfamilies of <italic>Fgfs</italic> (such as <italic>Fgf11-14</italic>) have alternative amino termini, which result from the use of alternative 5' exons. It is not known whether a common 5' untranslated exon splices to these exons or whether alternative promoter and regulatory sequences are used.</p><p>Most <italic>Fgf</italic> genes are found scattered throughout the genome. In human, 22 <italic>FGF</italic> genes have been identified and the chromosomal locations of all except <italic>FGF16</italic> are known (Table <xref ref-type="table" rid="T1">1</xref>) [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. Several human <italic>FGF</italic> genes are clustered within the genome. <italic>FGF3, FGF4</italic> and <italic>FGF19</italic> are located on chromosome 11q13 and are separated by only 40 and 10 kb, respectively; <italic>FGF6</italic> and <italic>FGF23</italic> are located within 55 kb on chromosome 12p13; and <italic>FGF17</italic> and <italic>FGF20</italic> map to chromosome 8p21-p22. These gene locations indicate that the <italic>FGF</italic> gene family was generated both by gene and chromosomal duplication and translocation during evolution. Interestingly, a transcriptionally active portion of human <italic>FGF7</italic>, located on chromosome 15q13-q22, has been amplified to about 16 copies, which are dispersed throughout the human genome [<xref ref-type="bibr" rid="B8">8</xref>].</p><p>In the mouse, there are at least 22 <italic>Fgf</italic> genes [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B9">9</xref>], and the locations of 16 have been identified (Table <xref ref-type="table" rid="T1">1</xref>). Many of the mouse <italic>Fgf</italic> genes are scattered throughout the genome, but as in the human, <italic>Fgf3, Fgf4</italic> and <italic>Fgf19</italic> are closely linked (within 80 kb on chromosome 7F) and <italic>Fgf6</italic> and <italic>Fgf23</italic> are closely linked on chromosome 6F3-G1.</p></sec><sec><title>Evolutionary history</title><p><italic>Fgfs</italic> have been identified in both invertebrates and vertebrates [<xref ref-type="bibr" rid="B3">3</xref>]. Interestingly, an <italic>Fgf</italic>-like gene is also encoded in the nuclear polyhedrosis virus genome [<xref ref-type="bibr" rid="B10">10</xref>]. <italic>Fgf</italic>-like sequences have not been found in unicellular organisms such as <italic>Escherichia coli</italic> and <italic>Saccharomyces cerevisiae</italic>. Although the <italic>Drosophila</italic> and <italic>Caenorhabditis elegans</italic> genomes have been sequenced, only one <italic>Fgf</italic> gene (<italic>branchless</italic>) has been identified in <italic>Drosophila</italic> [<xref ref-type="bibr" rid="B11">11</xref>] and two (<italic>egl-17</italic> and <italic>let-756</italic>) have been identified in <italic>C. elegans</italic> [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>], in contrast to the large number of <italic>Fgf</italic> genes identified in vertebrates. The evolutionary relationship between invertebrate and vertebrate <italic>Fgfs</italic> is shown in Figure <xref ref-type="fig" rid="F2">2a</xref>.</p><p>The <italic>Fgf</italic> gene expansion has been hypothesized to be coincident with a phase of global gene duplications that took place during the period leading to the emergence of vertebrates [<xref ref-type="bibr" rid="B14">14</xref>]. Across species, most orthologous FGF proteins are highly conserved and share greater than 90% amino-acid sequence identity (except human FGF15 and mouse Fgf19; see below). To date, four <italic>Fgfs</italic> (<italic>Fgf3, 8, 17</italic> and <italic>18</italic>) have been identified in zebrafish, seven (<italic>Fgf3, Fgf(i), Fgf(ii), Fgf8, 9</italic> and <italic>20</italic>) in Xenopus (<italic>Fgf(i)</italic> and <italic>Fgf(ii)</italic> are most closely related to Fgf4 and Fgf6 [<xref ref-type="bibr" rid="B15">15</xref>]) and seven (<italic>Fgf2, 4, 8, 12, 14, 18</italic> and <italic>19</italic>) in chicken [<xref ref-type="bibr" rid="B3">3</xref>].</p><p>The apparent evolutionary relationships of the 22 known human FGFs are shown in Figure <xref ref-type="fig" rid="F2">2b</xref>. Vertebrate FGFs can be classified into several subgroups or subfamilies. Members of a subgroup of FGFs share increased sequence similarity and biochemical and developmental properties. For example, members of the FGF8 subfamily (FGF8, FGF17, and FGF18) have 70-80% amino acid sequence identity, similar receptor-binding properties and some overlapping sites of expression (for example, the midbrain-hindbrain junction) [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. Members of FGF subgroups are not closely linked in the genome, however, indicating that the subfamilies were generated by gene-translocation or by genome-duplication events, not by local duplication events.</p><p>Human <italic>FGF15</italic> and mouse <italic>Fgf19</italic> have not been identified. Human <italic>FGF19</italic> is evolutionarily most closely related to mouse <italic>Fgf15</italic> (51% amino acid identity; Figure <xref ref-type="fig" rid="F2">2b</xref>) [<xref ref-type="bibr" rid="B18">18</xref>] and both the human <italic>FGF19</italic> and mouse <italic>Fgf15</italic> genes are closely linked to the human and mouse <italic>Fgf3</italic> and <italic>Fgf4</italic> genes on orthologous regions of human chromosome 11q13 and mouse chromosome 7F (N.I., unpublished observations). These findings indicate that human <italic>FGF19</italic> may be the human ortholog of mouse <italic>Fgf15</italic>. Because all other <italic>Fgf</italic> orthologs share greater than 90% amino acid identity, it remains possible that the true orthologs of these genes have not been identified, have been lost or have diverged during vertebrate evolution.</p></sec></sec><sec><title>Characteristic structural features</title><p>FGFs range in molecular weight from 17 to 34 kDa in vertebrates, whereas the <italic>Drosophila</italic> FGF is 84 kDa. Most FGFs share an internal core region of similarity, with 28 highly conserved and six identical amino-acid residues [<xref ref-type="bibr" rid="B19">19</xref>]. Ten of these highly conserved residues interact with the FGF receptor (FGFR) [<xref ref-type="bibr" rid="B20">20</xref>]. Structural studies on FGF1 and FGF2 identify 12 antiparallel &#x003b2; strands in the conserved core region of the protein (Figure <xref ref-type="fig" rid="F3">3</xref>) [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. FGF1 and FGF2 have a &#x003b2; trefoil structure that contains four-stranded &#x003b2; sheets arranged in a triangular array (Figure <xref ref-type="fig" rid="F3">3b</xref>; reviewed in [<xref ref-type="bibr" rid="B23">23</xref>]). Two &#x003b2; strands (strands &#x003b2;10 and &#x003b2;11) contain several basic amino-acid residues that form the primary heparin-binding site on FGF2. Regions thought to be involved in receptor binding are distinct from regions that bind heparin (Figure <xref ref-type="fig" rid="F3">3</xref>) [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>].</p></sec><sec><title>Localization and function</title><sec><title>Localization</title><sec><title>Subcellular localization and secretion</title><p>Most FGFs (FGFs 3-8, 10, 15, 17-19, and 21-23) have amino-terminal signal peptides and are readily secreted from cells. FGFs 9, 16 and 20 lack an obvious amino-terminal signal peptide but are nevertheless secreted [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. FGF1 and FGF2 also lack signal sequences, but, unlike FGF9, are not secreted; they can, however, befound on the cell surface and within the extracellular matrix. FGF1 and FGF2 may be released from damaged cells or could be released by an exocytotic mechanism that is independent of the endoplasmic-reticulum-Golgi pathway [<xref ref-type="bibr" rid="B28">28</xref>]. FGF9 has been shown to contain a non-cleaved amino-terminal hydrophobic sequence that is required for secretion [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. A third subset of FGFs (FGF11-14) lack signal sequences and are thought to remain intracellular [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. It is not known whether these FGFs interact with known FGFRs or function in a receptor-independent manner within the cell. FGF2 and FGF3 have high-molecular-weight forms that arise from initiation from upstream CUG codons [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. The additional amino-terminal sequence in these proteins contains nuclear-localization signals, and the proteins can be found in the nucleus; the biological function of nuclear-localized FGF is unclear.</p></sec><sec><title>Developmental expression patterns and function</title><p>The 22 members of the mammalian FGF family are differentially expressed in many, if not all, tissues, but the patterns and timing of expression vary. Subfamilies of FGFs tend to have similar patterns of expression, although each FGF also appears to have unique sites of expression. Some FGFs are expressed exclusively during embryonic development (for example, <italic>Fgf3, 4, 8, 15, 17</italic> and <italic>19</italic>), whereas others are expressed in embryonic and adult tissues (for example, <italic>Fgf1, 2, 5-7, 9-14, 16, 18</italic>, and <italic>20-23</italic>).</p></sec></sec><sec><title>Function</title><p>The expression patterns of FGFs (see above) suggest that they have important roles in development. FGFs often signal directionally and reciprocally across epithelial-mesenchymal boundaries [<xref ref-type="bibr" rid="B36">36</xref>]. The integrity of these signaling pathways requires extremely tight regulation of FGF activity and receptor specificity. For example, in vertebrate limb development, mesenchymally expressed <italic>Fgf10</italic> in the lateral-plate mesoderm induces the formation of the overlying apical ectodermal ridge; the ridge subsequently expresses <italic>Fgf8</italic>, which signals back to the underlying mesoderm [<xref ref-type="bibr" rid="B37">37</xref>]. This directional signaling initiates feedback loops and, along with other signaling molecules, regulates the outgrowth and patterning of the limb. Importantly, the differential expression of the alternative splice forms of the receptors in the apical ectodermal ridge and underlying mesoderm is such as to limit or prevent autocrine signaling within a given compartment.</p><p>Studies of the biochemical activities of FGFs have focused on the specificity of interactions between FGFs and FGFRs, on factors that affect the stability of FGFs and on the composition and mechanism of the active FGF-FGFR signaling complex.</p><sec><title>Specificity of FGFs for FGF receptors</title><p>The FGFR tyrosine kinase receptors contain two or three immunoglobulin-like domains and a heparin-binding sequence [<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B40">40</xref>]. Alternative mRNA splicing of the FGFR gene specifies the sequence of the carboxy-terminal half of immunoglobulin-domain III, resulting in either the IIIb or the IIIc isoform of the FGFR [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. This alternative-splicing event is regulated in a tissue-specific manner and dramatically affects ligand-receptor binding specificity [<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B48">48</xref>]. Exon IIIb is expressed in epithelial lineages and exon IIIc tends to be expressed in mesenchymal lineages [<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B48">48</xref>]. <italic>In vitro</italic> patterns of binding specificity have been determined for each splice form of FGFR1-3 and for FGFR4, which is not alternatively spliced [<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B51">51</xref>]. Ligands specific for these receptor splice forms are expressed in adjacent tissues, resulting in directional epithelial-mesenchymal signaling. For example, epithelially expressed FGFR2b (that is, FGFR2 IIIb isoform) can be activated by FGF7 and FGF10, ligands produced in mesenchymal tissue [<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B51">51</xref>]. These ligands show no activity towards mesenchymally expressed FGFR2c. Conversely, FGF8 is expressed in epithelial tissue and activates FGFR2c but shows no activity towards FGFR2b ([<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B52">52</xref>] and our unpublished observations). Notably, FGF8 expression is often restricted to epithelial tissue such as the apical ectodermal ridge of the developing limb bud [<xref ref-type="bibr" rid="B53">53</xref>,<xref ref-type="bibr" rid="B54">54</xref>].</p></sec><sec><title>Interaction with heparin or heparan sulfate proteoglycans</title><p>An important feature of FGF biology involves the interaction between FGF and heparin or heparan sulfate (HS) proteoglycan (HSPG) [<xref ref-type="bibr" rid="B19">19</xref>]. These interactions stabilize FGFs to thermal denaturation and proteolysis and may severely limit their diffusion and release into interstitial spaces [<xref ref-type="bibr" rid="B55">55</xref>,<xref ref-type="bibr" rid="B56">56</xref>]. FGFs must saturate nearby HS-binding sites before exerting an effect on tissue further away, or else must be mobilized by heparin/HS-degrading enzymes. The interaction between FGFs and HS results in the formation of dimers and higher-order oligomers [<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B58">58</xref>,<xref ref-type="bibr" rid="B59">59</xref>]. Although the biologically active form of FGF is poorly defined, it has been established that heparin is required for FGF to effectively activate the FGFR in cells that are deficient in or unable to synthesize HSPG or in cells pretreated with heparin/HS-degrading enzymes or inhibitors of sulfation [<xref ref-type="bibr" rid="B60">60</xref>,<xref ref-type="bibr" rid="B61">61</xref>,<xref ref-type="bibr" rid="B62">62</xref>]. Genetic studies have also shown that mutations in enzymes involved in HS biosynthesis affect FGF signaling pathways during development [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B63">63</xref>]. Additional studies have shown that heparin and/or HS act to increase the affinity and half-life of the FGF-FGFR complex (reviewed in [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B64">64</xref>]).</p><p>A minimal complex containing one FGF molecule per FGFR can form in the absence of HS [<xref ref-type="bibr" rid="B24">24</xref>]. Structural studies suggest that HS may bridge FGF2 and the FGFR by binding to a groove formed by the heparan-binding sites of both the ligand and the receptor [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B65">65</xref>]. Binding studies with soluble chimeric FGFRs have identified a second potential FGF-binding site that, in some cases, can interact cooperatively with the primary FGF-binding site [<xref ref-type="bibr" rid="B66">66</xref>].</p></sec></sec><sec><title>Important mutants</title><p>Many members of the <italic>Fgf</italic> family have been disrupted by homologous recombination in mice. The phenotypes range from very early embryonic lethality to subtle phenotypes in adult mice. The major phenotypes observed in <italic>Fgf</italic> knockout mice are shown in Table <xref ref-type="table" rid="T2">2</xref>. Because FGFs within a subfamily have similar receptor-binding properties and overlapping patterns of expression, functional redundancy is likely to occur. This has been demonstrated for <italic>Fgf17</italic> and <italic>Fgf8</italic>, which cooperate to regulate neuroepithelial proliferation in the midbrain-hindbrain junction [<xref ref-type="bibr" rid="B17">17</xref>]. In the case of <italic>Fgf</italic> knockouts resulting in early lethality, other functions later in development will need to be addressed by constructing conditional alleles that can be targeted at specific times and places in development. For example, <italic>Fgf8</italic><sup>-/-</sup> mice die by embryonic day 9.5 [<xref ref-type="bibr" rid="B67">67</xref>]. A conditional allele for <italic>Fgf8</italic> targeted to the apical ectodermal ridge has been used to demonstrate an essential role for <italic>Fgf8</italic> in early limb development [<xref ref-type="bibr" rid="B68">68</xref>,<xref ref-type="bibr" rid="B69">69</xref>].</p><p>Several mutations in <italic>Fgf</italic> genes have been identified in <italic>C. elegans, Drosophila</italic>, zebrafish, mouse and human. The <italic>C. elegans</italic> gene <italic>egl-17</italic> is required for sex myoblast migration [<xref ref-type="bibr" rid="B12">12</xref>], and a null allele of <italic>let-756</italic> causes developmental arrest of the early larva [<xref ref-type="bibr" rid="B13">13</xref>]. The <italic>Drosophila branchless</italic> gene is required for tracheal branching and cell migration [<xref ref-type="bibr" rid="B11">11</xref>]. In zebrafish, <italic>acerebellar (ace)</italic> embryos lack the cerebellum and the midbrain-hindbrain boundary organizer. The <italic>ace</italic> gene encodes the zebrafish homolog of <italic>Fgf8</italic> [<xref ref-type="bibr" rid="B70">70</xref>]. Interestingly, zebrafish <italic>aussicht</italic> mutant embryos, which overexpress <italic>Fgf8</italic>, also have defects in development of the central nervous system [<xref ref-type="bibr" rid="B71">71</xref>].</p><p>In the mouse, the <italic>angora</italic> mutation, which affects hair growth, was found to be allelic with <italic>Fgf5</italic> [<xref ref-type="bibr" rid="B72">72</xref>]. A mouse mutant with a Crouzon-syndrome-like craniofacial dysmorphology phenotype was found to result from an insertional mutation in the <italic>Fgf3/Fgf4</italic> locus [<xref ref-type="bibr" rid="B73">73</xref>]. Recently, positional cloning of the autosomal dominant hypophosphataemic rickets gene identified missense mutations in human FGF23 [<xref ref-type="bibr" rid="B74">74</xref>]. A recent paper demonstrates that this disease is caused by a gain-of-function mutation [<xref ref-type="bibr" rid="B75">75</xref>]. The chromosomal location (Xq26) and tissue-specific expression pattern of <italic>Fgf13</italic> (also called <italic>Fhf2</italic>) suggests that it may be a candidate gene for Borjeson-Forssman-Lehmann syndrome, an X-linked mental retardation syndrome [<xref ref-type="bibr" rid="B76">76</xref>].</p></sec></sec><sec><title>Frontiers</title><sec><title>Issues most studied</title><p>FGFs have been intensely studied for nearly 30 years. Most of the early work focused on the mechanisms that regulate stability, secretion, export and interactions with heparin and on the mechanisms and consequences of signal transduction in various types of cells. More recent work has focused on the mechanisms regulating receptor specificity and receptor activation, the structure of the FGF-FGFR-HS complex, and the identification of new members of the FGF family. Functional studies have begun to address the role of FGFs in cell biology, development and physiology. Initial studies focused on the regulation of cell proliferation, migration and differentiation; more recent work has addressed the negative effect of FGFs and FGFRs on proliferation of some cell types, which was surprising as FGFs were thought to promote proliferation. <italic>In vitro</italic> studies have now been complemented by gene targeting in mice. The knockout approach has been fairly successful in identifying primary phenotypes but will be challenged by the need to address redundancy amongst the 22 FGFs and to study their developmental and physiological functions after the point of lethality of the null allele.</p></sec><sec><title>Unresolved questions</title><p>A major unresolved question concerns the mechanism(s) regulating FGF activity <italic>in vivo</italic> in the presence of cell-surface and extracellular-matrix HSPG. Current hypotheses predict that tissue-specific heparan fragments of defined sequence (and particularly of defined sulfation pattern) will differentially regulate FGFs by controlling their diffusion in the extracellular matrix and their ability to activate specific receptors [<xref ref-type="bibr" rid="B77">77</xref>]. These issues will be resolved by determining the sequence of tissue-specific HS and by demonstrating whether specific HS sequences can modulate the binding specificity of FGFs beyond that determined by the specific FGFR and its alternative splice form in the presence of heparin.</p><p>A second area of research will aim to elucidate the developmental roles of all the FGFs, first alone and then in various combinations. This will include determining whether a single FGF with a defined developmental function interacts with one or multiple FGFRs. A third major frontier will be to elucidate the physiological roles of FGFs that are expressed in adult tissues. This will again involve testing combinations of FGFs in cases in which knockouts are viable and designing conditional alleles in cases of embryonic lethality. Major areas being considered include neuronal and cardiovascular physiology, neuronal regeneration and homeostasis and tissue repair.</p><p>The last major frontier will be to elucidate the primary roles of FGFs in genetic diseases and cancer. Several FGFs were initially cloned from human and animal tumors. Future work will be required to determine whether FGF activation is itself an etiological agent in primary human tumors or whether it is a progression factor in the pathogenesis of cancer. As functional roles for FGFs are elucidated in embryonic development, it is expected that various human birth defects and genetic diseases will be attributed to mutations in <italic>Fgf</italic> genes. These studies will probably lead to the development of pharmacogenetic agents to treat these diseases. Because a large number of skeletal diseases are caused by mutations in <italic>Fgfr</italic> genes, it is anticipated that mutations in some <italic>Fgf</italic> genes will also be involved in skeletal pathology.</p></sec></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work was supported by NIH grants CA60673 and HD35692 and by a grant from the American Heart Association (to D.M.O.) and by the Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan and a grant from the Human Frontier Science Program, France (to N.I.).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kiefer</surname><given-names>P</given-names></name><name><surname>Acland</surname><given-names>P</given-names></name><name><surname>Pappin</surname><given-names>D</given-names></name><name><surname>Peters</surname><given-names>G</given-names></name><name><surname>Dickson</surname><given-names>C</given-names></name></person-group><article-title>Competition between nuclear localization and secretory signals determines the subcellular fate of a single CUG-initiated form of FGF3.</article-title><source>EMBO J</source><year>1994</year><volume>13</volume><fpage>4126</fpage><lpage>4136</lpage><comment>This is one of first papers to show that an FGF can initiate from an upstream CUG codon and can be localized in the nucleus.</comment><pub-id pub-id-type="pmid">8076608</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnaud</surname><given-names>E</given-names></name><name><surname>Touriol</surname><given-names>C</given-names></name><name><surname>Boutonnet</surname><given-names>C</given-names></name><name><surname>Gensac</surname><given-names>MC</given-names></name><name><surname>Vagner</surname><given-names>S</given-names></name><name><surname>Prats</surname><given-names>H</given-names></name><name><surname>Prats</surname><given-names>AC</given-names></name></person-group><article-title>A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor.</article-title><source>Mol Cell Biol</source><year>1999</year><volume>19</volume><fpage>505</fpage><lpage>514</lpage><comment>Identification of a high-molecular-weight form of FGF2 that initiates from an upsteam CUG codon and is localized in the nucleus.</comment><pub-id pub-id-type="pmid">9858574</pub-id></citation></ref><ref id="B3"><citation citation-type="other"><article-title>GenBank</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Genbank/index.html"/><comment>DNA sequences of FGFs listed in Table 1 can be accessed through this website.</comment></citation></ref><ref id="B4"><citation citation-type="other"><article-title>HUGO Gene Nomenclature Database</article-title><ext-link ext-link-type="uri" xlink:href="http://www.gene.ucl.ac.uk/nomenclature/"/><comment>This database contains nomenclature and mapping information for human genes.</comment></citation></ref><ref id="B5"><citation citation-type="other"><article-title>Cytokine Family cDNA Database</article-title><ext-link ext-link-type="uri" xlink:href="http://cytokine.medic.kumamoto-u.ac.jp/CFC/FGF/FGF.html"/><comment>This database contains nomenclature and mapping information for the FGF family.</comment></citation></ref><ref id="B6"><citation citation-type="other"><article-title>LocusLink</article-title><ext-link ext-link-type="uri" xlink:href="http://ncbi.nlm.nih.gov/LocusLink/"/><comment>This database contains updated mapping information for the FGF family with links to a variety of other databases.</comment></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>T</given-names></name><name><surname>Yoshioka</surname><given-names>M</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name></person-group><article-title>Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain.</article-title><source>Biochem Biophys Res Commun</source><year>2000</year><volume>277</volume><fpage>494</fpage><lpage>498</lpage><comment>FGF23 is the most recent reported member of the FGF family. This paper summarizes the chromosomal localization and apparent evolutionary relationships of human FGFs.</comment><pub-id pub-id-type="pmid">11032749</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.2000.3696</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelley</surname><given-names>MJ</given-names></name><name><surname>Pech</surname><given-names>M</given-names></name><name><surname>Seuanez</surname><given-names>HN</given-names></name><name><surname>Rubin</surname><given-names>JS</given-names></name><name><surname>O'Brien</surname><given-names>SJ</given-names></name><name><surname>Aaronson</surname><given-names>SA</given-names></name></person-group><article-title>Emergence of the keratinocyte growth factor multigene family during the great ape radiation.</article-title><source>Proc Natl Acad Sci USA</source><year>1992</year><volume>89</volume><fpage>9287</fpage><lpage>9291</lpage><comment>This paper identifies a human multigene family composed of amplified and dispersed FGF7 gene copies and suggests models for the evolution of the great apes and humans.</comment><pub-id pub-id-type="pmid">1409637</pub-id></citation></ref><ref id="B9"><citation citation-type="other"><article-title>Mouse Genome Informatics</article-title><ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org"/><comment>This website provides information on mouse gene sequences, map position and function.</comment></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ayres</surname><given-names>MD</given-names></name><name><surname>Howard</surname><given-names>SC</given-names></name><name><surname>Kuzio</surname><given-names>J</given-names></name><name><surname>Lopez-Ferber</surname><given-names>M</given-names></name><name><surname>Possee</surname><given-names>RD</given-names></name></person-group><article-title>The complete DNA sequence of <italic>Autographa californica</italic> nuclear polyhedrosis virus.</article-title><source>Virology</source><year>1994</year><volume>202</volume><fpage>586</fpage><lpage>605</lpage><comment>The complete nucleotide sequence of the genome of the baculovirus <italic>Autographa californica</italic> nuclear polyhedrosis virus (AcNPV) revealed that this genome encodes an FGF-like protein.</comment><pub-id pub-id-type="pmid">8030224</pub-id><pub-id pub-id-type="doi">10.1006/viro.1994.1380</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sutherland</surname><given-names>D</given-names></name><name><surname>Samakovlis</surname><given-names>C</given-names></name><name><surname>Krasnow</surname><given-names>MA</given-names></name></person-group><article-title>branchless encodes a <italic>Drosophila</italic> FGF homolog that controls tracheal cell migration and the pattern of branching.</article-title><source>Cell</source><year>1996</year><volume>87</volume><fpage>1091</fpage><lpage>1101</lpage><comment>This paper identifies a <italic>Drosophila</italic> homolog (<italic>branchless, bnl</italic>) of mammalian FGFs, which activates the breathless FGF receptor tyrosine kinase. This FGF pathway regulates tracheal branching patterns by guiding tracheal cell migration during primary branch formation and by activating cytoplasmic branching at the ends of primary branches.</comment><pub-id pub-id-type="pmid">8978613</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burdine</surname><given-names>RD</given-names></name><name><surname>Chen</surname><given-names>EB</given-names></name><name><surname>Kwok</surname><given-names>SF</given-names></name><name><surname>Stern</surname><given-names>MJ</given-names></name></person-group><article-title><italic>egl-17</italic> encodes an invertebrate fibroblast growth factor family member required specifically for sex myoblast migration in <italic>Caenorhabditis elegans</italic>.</article-title><source>Proc Natl Acad Sci USA</source><year>1997</year><volume>94</volume><fpage>2433</fpage><lpage>2437</lpage><comment>The <italic>C. elegans</italic> gene <italic>egl-17</italic> is a member of the <italic>Fgf</italic> family and one of the first known functional invertebrate FGFs. EGL-17 acts as a ligand for EGL-15 (FGFR) to regulate sex myoblast migration.</comment><pub-id pub-id-type="pmid">9122212</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roubin</surname><given-names>R</given-names></name><name><surname>Naert</surname><given-names>K</given-names></name><name><surname>Popovici</surname><given-names>C</given-names></name><name><surname>Vatcher</surname><given-names>G</given-names></name><name><surname>Coulier</surname><given-names>F</given-names></name><name><surname>Thierry-Mieg</surname><given-names>J</given-names></name><name><surname>Pontarotti</surname><given-names>P</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name><name><surname>Baillie</surname><given-names>D</given-names></name><name><surname>Thierry-Mieg</surname><given-names>D</given-names></name></person-group><article-title>let-756, a <italic>C. elegans</italic> Fgf essential for worm development.</article-title><source>Oncogene</source><year>1999</year><volume>18</volume><fpage>6741</fpage><lpage>6747</lpage><comment>Null mutations in <italic>C. elegansl et-756</italic> lead to developmental arrest in early larval stages; <italic>let-756</italic> is thus an essential gene for <italic>C. elegans</italic> development.</comment><pub-id pub-id-type="pmid">10597282</pub-id><pub-id pub-id-type="doi">10.1038/sj/onc/1203074</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coulier</surname><given-names>F</given-names></name><name><surname>Pontarotti</surname><given-names>P</given-names></name><name><surname>Roubin</surname><given-names>R</given-names></name><name><surname>Hartung</surname><given-names>H</given-names></name><name><surname>Goldfarb</surname><given-names>M</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name></person-group><article-title>Of worms and men: an evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families.</article-title><source>J Mol Evol</source><year>1997</year><volume>44</volume><fpage>43</fpage><lpage>56</lpage><comment>This review compares FGF and FGF receptor sequences in vertebrates and nonvertebrates and concludes that the FGF and FGF receptor families have evolved through phases of gene duplications, one of which may have coincided with the emergence of vertebrates. The review includes all four <italic>Fgfrs</italic> and 11 <italic>Fgfs</italic>.</comment><pub-id pub-id-type="pmid">9010135</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Isaacs</surname><given-names>HV</given-names></name><name><surname>Tannahill</surname><given-names>D</given-names></name><name><surname>Slack</surname><given-names>JM</given-names></name></person-group><article-title>Expression of a novel FGF in the <italic>Xenopus</italic> embryo. A new candidate inducing factor for mesoderm formation and anteroposterior specification.</article-title><source>Development</source><year>1992</year><volume>114</volume><fpage>711</fpage><lpage>720</lpage><comment>Identification of novel <italic>Xenopus</italic> FGFs.</comment><pub-id pub-id-type="pmid">1618138</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maruoka</surname><given-names>Y</given-names></name><name><surname>Ohbayashi</surname><given-names>N</given-names></name><name><surname>Hoshikawa</surname><given-names>M</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name><name><surname>Hogan</surname><given-names>BLM</given-names></name><name><surname>Furuta</surname><given-names>Y</given-names></name></person-group><article-title>Comparison of the expression of three highly related genes, <italic>Fgf8</italic>, <italic>Fgf17</italic> and <italic>Fgf18</italic>, in the mouse embryo.</article-title><source>Mech Dev</source><year>1998</year><volume>74</volume><fpage>175</fpage><lpage>177</lpage><comment>This paper compares the expression pattern of the <italic>Fgf8</italic> subfamily which includes <italic>Fgf8, 17</italic> and <italic>18</italic>. Expression is examined during early development and in the developing brain and limbs.</comment><pub-id pub-id-type="pmid">9651520</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>JS</given-names></name><name><surname>Liu</surname><given-names>ZH</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>Temporal and spatial gradients of Fgf8 and Fgf17 regulate proliferation and differentiation of midline cerebellar structures.</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>1833</fpage><lpage>1843</lpage><comment>This is the first paper to demonstrate cooperation between two <italic>Fgfs</italic> during vertebrate development.</comment><pub-id pub-id-type="pmid">10751172</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Utsunomiya</surname><given-names>Y</given-names></name><name><surname>Hoshikawa</surname><given-names>M</given-names></name><name><surname>Ohuchi</surname><given-names>H</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name></person-group><article-title>Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain.</article-title><source>Biochim Biophys Acta</source><year>1999</year><volume>1444</volume><fpage>148</fpage><lpage>151</lpage><comment>Identification of human <italic>FGF19</italic> as a possible homolog of mouse <italic>Fgf15</italic>. Both of these genes are most closely related to <italic>FGFs</italic> 21 and 23.</comment><pub-id pub-id-type="pmid">9931477</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>FGFs, heparan sulfate and FGFRs: complex interactions essential for development.</article-title><source>BioEssays</source><year>2000</year><volume>22</volume><fpage>108</fpage><lpage>112</lpage><comment>This review article addresses the developmental implications of the interactions between FGFs, FGFRs and heparan sulfate proteoglycans. The paper by Lin <italic>et al.</italic> [63], which demonstrates that heparan sulfate is essential for FGF function during <italic>Drosophila</italic> development, is highlighted.</comment><pub-id pub-id-type="pmid">10655030</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1521-1878(200002)22:2&#x0003c;108::AID-BIES2&#x0003e;3.0.CO;2-M</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plotnikov</surname><given-names>AN</given-names></name><name><surname>Hubbard</surname><given-names>SR</given-names></name><name><surname>Schlessinger</surname><given-names>J</given-names></name><name><surname>Mohammadi</surname><given-names>M</given-names></name></person-group><article-title>Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity.</article-title><source>Cell</source><year>2000</year><volume>101</volume><fpage>413</fpage><lpage>424</lpage><comment>The analysis of two different ligand-receptor crystal structures is used to determine elements that regulate ligand-binding specificity.</comment><pub-id pub-id-type="pmid">10830168</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Komiya</surname><given-names>H</given-names></name><name><surname>Chirino</surname><given-names>A</given-names></name><name><surname>Faham</surname><given-names>S</given-names></name><name><surname>Fox</surname><given-names>GM</given-names></name><name><surname>Arakawa</surname><given-names>T</given-names></name><name><surname>Hsu</surname><given-names>BT</given-names></name><name><surname>Rees</surname><given-names>DC</given-names></name></person-group><article-title>Three-dimensional structures of acidic and basic fibroblast growth factors.</article-title><source>Science</source><year>1991</year><volume>251</volume><fpage>90</fpage><lpage>93</lpage><comment>This paper presents one of the first structures of FGF1 and FGF2.</comment><pub-id pub-id-type="pmid">1702556</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>AE</given-names></name><name><surname>Cousens</surname><given-names>LS</given-names></name><name><surname>Weaver</surname><given-names>LH</given-names></name><name><surname>Matthews</surname><given-names>BW</given-names></name></person-group><article-title>Three-dimensional structure of human basic fibroblast growth factor.</article-title><source>Proc Natl Acad Sci USA</source><year>1991</year><volume>88</volume><fpage>3441</fpage><lpage>3445</lpage><comment>This paper presents one of the first structures of FGF2.</comment><pub-id pub-id-type="pmid">1707542</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faham</surname><given-names>S</given-names></name><name><surname>Linhardt</surname><given-names>RJ</given-names></name><name><surname>Rees</surname><given-names>DC</given-names></name></person-group><article-title>Diversity does make a difference: fibroblast growth factor-heparin interactions.</article-title><source>Curr Opin Struct Biol</source><year>1998</year><volume>8</volume><fpage>578</fpage><lpage>586</lpage><comment>A review that models the formation of an FGF-FGFR-proteoglycan complex, based on the structure of FGF in complex with fragments of heparin.</comment><pub-id pub-id-type="pmid">9818261</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plotnikov</surname><given-names>AN</given-names></name><name><surname>Schlessinger</surname><given-names>J</given-names></name><name><surname>Hubbard</surname><given-names>SR</given-names></name><name><surname>Mohammadi</surname><given-names>M</given-names></name></person-group><article-title>Structural basis for FGF receptor dimerization and activation.</article-title><source>Cell</source><year>1999</year><volume>98</volume><fpage>641</fpage><lpage>650</lpage><comment>Crystal structure of FGF2 complexed with FGFR1 showing extensive interaction between immunoglobulin domains 2 and 3 and the interdomain linker of the FGFR.</comment><pub-id pub-id-type="pmid">10490103</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyake</surname><given-names>A</given-names></name><name><surname>Konishi</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>FH</given-names></name><name><surname>Hernday</surname><given-names>NA</given-names></name><name><surname>Ozaki</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Mikami</surname><given-names>T</given-names></name><name><surname>Arakawa</surname><given-names>T</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name></person-group><article-title>Structure and expression of a novel member, FGF-16, of the fibroblast growth factor family.</article-title><source>Biochem Biophys Res Commun</source><year>1998</year><volume>243</volume><fpage>148</fpage><lpage>152</lpage><comment>This paper identifies <italic>Fgf16</italic> as a homolog of <italic>Fgf9</italic>.</comment><pub-id pub-id-type="pmid">9473496</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.1998.8073</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname><given-names>M</given-names></name><name><surname>Naruo</surname><given-names>K</given-names></name><name><surname>Seko</surname><given-names>C</given-names></name><name><surname>Matsumoto</surname><given-names>S</given-names></name><name><surname>Kondo</surname><given-names>T</given-names></name><name><surname>Kurokawa</surname><given-names>T</given-names></name></person-group><article-title>Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property.</article-title><source>Mol Cell Biol</source><year>1993</year><volume>13</volume><fpage>4251</fpage><lpage>4259</lpage><comment>This paper identifies FGF9 as a new member of the FGF family without a classical signal peptide.</comment><pub-id pub-id-type="pmid">8321227</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohmachi</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>Y</given-names></name><name><surname>Mikami</surname><given-names>T</given-names></name><name><surname>Kusu</surname><given-names>N</given-names></name><name><surname>Ibi</surname><given-names>T</given-names></name><name><surname>Akaike</surname><given-names>A</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name></person-group><article-title>FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain.</article-title><source>Biochem Biophys Res Commun</source><year>2000</year><volume>277</volume><fpage>355</fpage><lpage>360</lpage><comment>This paper identifies <italic>Fgf20</italic> as a homolog of <italic>Fgf9</italic> and <italic>Fgf16</italic>.</comment><pub-id pub-id-type="pmid">11032730</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.2000.3675</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mignatti</surname><given-names>P</given-names></name><name><surname>Morimoto</surname><given-names>T</given-names></name><name><surname>Rifkin</surname><given-names>DB</given-names></name></person-group><article-title>Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex.</article-title><source>J Cell Physiol</source><year>1992</year><volume>151</volume><fpage>81</fpage><lpage>93</lpage><comment>FGF2 lacks a signal peptide but is known to act extracellularly. This study shows that FGF2 can be released via an exocytotic mechanism independent of the endoplasmic reticulum-Golgi pathway.</comment><pub-id pub-id-type="pmid">1560052</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyakawa</surname><given-names>K</given-names></name><name><surname>Hatsuzawa</surname><given-names>K</given-names></name><name><surname>Kurokawa</surname><given-names>T</given-names></name><name><surname>Asada</surname><given-names>M</given-names></name><name><surname>Kuroiwa</surname><given-names>T</given-names></name><name><surname>Imamura</surname><given-names>T</given-names></name></person-group><article-title>A hydrophobic region locating at the center of fibroblast growth factor-9 is crucial for its secretion.</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>29352</fpage><lpage>29357</lpage><comment>FGF9 lacks an amino-terminal signal sequence but is secreted from expressing cells. This study shows that nascent FGF9 polypeptides translocate into endoplasmic reticulum without peptide cleavage via a co-translational pathway in which both an amino terminus and a central hydrophobic domain is important.</comment><pub-id pub-id-type="pmid">10506195</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Revest</surname><given-names>JM</given-names></name><name><surname>DeMoerlooze</surname><given-names>L</given-names></name><name><surname>Dickson</surname><given-names>C</given-names></name></person-group><article-title>Fibroblast growth factor 9 secretion is mediated by a non-cleaved amino-terminal signal sequence.</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>8083</fpage><lpage>8090</lpage><comment>FGF9 lacks a recognizable amino-terminal signal sequence, although it is efficiently secreted. This study shows that FGF9 enters the endoplasmic reticulum and traverses the Golgi complex in a similar manner to other constitutively secreted proteins. They demonstrate that the first 28 amino acids of FGF9 can function as an efficient non-cleaved signal peptide.</comment><pub-id pub-id-type="pmid">10713129</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smallwood</surname><given-names>PM</given-names></name><name><surname>Munoz-sanjuan</surname><given-names>I</given-names></name><name><surname>Tong</surname><given-names>P</given-names></name><name><surname>Macke</surname><given-names>JP</given-names></name><name><surname>Hendry</surname><given-names>SH</given-names></name><name><surname>Gilbert</surname><given-names>DJ</given-names></name><name><surname>Copeland</surname><given-names>NG</given-names></name><name><surname>Jenkins</surname><given-names>NA</given-names></name><name><surname>Nathans</surname><given-names>J</given-names></name></person-group><article-title>Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development.</article-title><source>Proc Natl Acad Sci USA</source><year>1996</year><volume>93</volume><fpage>9850</fpage><lpage>9857</lpage><comment>This study identifies a novel FGF-related subfamily, termed fibroblast growth factor homologous factors (FHF). FHFs lack a classical signal sequence and contain nuclear localization signals. FHFs are expressed in the developing and adult nervous systems, suggesting a role in nervous system development and function.</comment><pub-id pub-id-type="pmid">8790420</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Mikami</surname><given-names>T</given-names></name><name><surname>Ohbayashi</surname><given-names>N</given-names></name><name><surname>Ohta</surname><given-names>M</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name></person-group><article-title>Structure and expression of a novel isoform of mouse FGF homologous factor (FHF)-4.</article-title><source>Biochim Biophys Acta</source><year>1998</year><volume>1398</volume><fpage>38</fpage><lpage>41</lpage><comment>Identification of alternative amino terminal coding exon for FHF4/FGF14.</comment><pub-id pub-id-type="pmid">9602045</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munoz-Sanjuan</surname><given-names>I</given-names></name><name><surname>Smallwood</surname><given-names>PM</given-names></name><name><surname>Nathans</surname><given-names>J</given-names></name></person-group><article-title>Isoform diversity among fibroblast growth factor homologous factors is generated by alternative promoter usage and differential splicing.</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>2589</fpage><lpage>2597</lpage><comment>Characterization of multiple isoforms of <italic>Fhfs1-4/Fgfs 11-14</italic>, generated through the use of alternative 5' exons. Isoforms show different subcellular distributions and distinct expression patterns in developing and adult mouse tissues.</comment><pub-id pub-id-type="pmid">10644718</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>McEwen</surname><given-names>DG</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>Subcellular and developmental expression of alternatively spliced forms of fibroblast growth factor 14.</article-title><source>Mech Dev</source><year>2000</year><volume>90</volume><fpage>283</fpage><lpage>287</lpage><comment>Identification of isoforms of <italic>Fhf4/Fgf14</italic> that result from the alternative usage of two different first exons. Isoforms show different subcellular localization and distinct expression patterns in developing and adult mouse tissues. Expression was observed in migrating and post migratory neurons.</comment><pub-id pub-id-type="pmid">10640713</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antoine</surname><given-names>M</given-names></name><name><surname>Reimers</surname><given-names>K</given-names></name><name><surname>Dickson</surname><given-names>C</given-names></name><name><surname>Kiefer</surname><given-names>P</given-names></name></person-group><article-title>Fibroblast growth factor 3, a protein with dual subcellular localization, is targeted to the nucleus and nucleolus by the concerted action of two nuclear localization signals and a nucleolar retention signal.</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>29475</fpage><lpage>29481</lpage><comment>Identification of an FGF3 CUG initiation site. This amino-terminal extended product is localized in both the nucleus/nucleolus and secretory pathway. The amino terminus contains both a signal sequence and a nuclear localization signal.</comment><pub-id pub-id-type="pmid">9368007</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname><given-names>BL</given-names></name></person-group><article-title>Morphogenesis.</article-title><source>Cell</source><year>1999</year><volume>96</volume><fpage>225</fpage><lpage>233</lpage><comment>Review article highlighting the roles of multigene families, such as <italic>Fgfs, Bmps, Hedgehogs, Wnts</italic> and <italic>Egfs</italic> in morphogenesis.</comment><pub-id pub-id-type="pmid">9988217</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><article-title>The roles of FGFs in the early development of vertebrate limbs.</article-title><source>Genes Dev</source><year>1998</year><volume>12</volume><fpage>1571</fpage><lpage>1586</lpage><comment>Review article summarizing data on the role of FGFs in vertebrate limb development. Demonstrates that FGFs play essential roles in signaling centers that control establishment, outgrowth and patterning of the limb bud.</comment><pub-id pub-id-type="pmid">9620845</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PL</given-names></name><name><surname>Johnson</surname><given-names>DE</given-names></name><name><surname>Cousens</surname><given-names>LS</given-names></name><name><surname>Fried</surname><given-names>VA</given-names></name><name><surname>Williams</surname><given-names>LT</given-names></name></person-group><article-title>Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor.</article-title><source>Science</source><year>1989</year><volume>245</volume><fpage>57</fpage><lpage>60</lpage><comment>This is the first cloning of an FGF receptor.</comment><pub-id pub-id-type="pmid">2544996</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>DE</given-names></name><name><surname>Lee</surname><given-names>PL</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>LT</given-names></name></person-group><article-title>Diverse forms of a receptor for acidic and basic fibroblast growth factors.</article-title><source>Mol Cell Biol</source><year>1990</year><volume>10</volume><fpage>4728</fpage><lpage>4736</lpage><comment>Identification of FGF receptor 1 variants which contain either two or three immunoglobulin-like domains. Identification of putative secreted forms of FGF receptor 1.</comment><pub-id pub-id-type="pmid">2167437</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McKeehan</surname><given-names>WL</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Kan</surname><given-names>M</given-names></name></person-group><article-title>The heparan sulfate-fibroblast growth factor family: diversity of structure and function.</article-title><source>Prog Nucleic Acid Res Mol Biol</source><year>1998</year><volume>59</volume><fpage>135</fpage><lpage>176</lpage><comment>This review presents models for FGF receptor activation by FGF and heparin. Also discussed are developmental roles for FGFs in liver and prostate development.</comment><pub-id pub-id-type="pmid">9427842</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miki</surname><given-names>T</given-names></name><name><surname>Bottaro</surname><given-names>DP</given-names></name><name><surname>Fleming</surname><given-names>TP</given-names></name><name><surname>Smith</surname><given-names>CL</given-names></name><name><surname>Burgess</surname><given-names>WH</given-names></name><name><surname>Chan</surname><given-names>AM</given-names></name><name><surname>Aaronson</surname><given-names>SA</given-names></name></person-group><article-title>Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.</article-title><source>Proc Natl Acad Sci USA</source><year>1992</year><volume>89</volume><fpage>246</fpage><lpage>250</lpage><comment>Demonstration that FGFR alternative splicing can regulate ligand binding specificity.</comment><pub-id pub-id-type="pmid">1309608</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chellaiah</surname><given-names>AT</given-names></name><name><surname>McEwen</surname><given-names>DG</given-names></name><name><surname>Werner</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1.</article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><fpage>11620</fpage><lpage>11627</lpage><comment>Identification of an alternative splice form of FGFR3 with very restricted ligand binding properties.</comment><pub-id pub-id-type="pmid">7512569</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naski</surname><given-names>MC</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>FGF signaling in skeletal development.</article-title><source>Front Biosci</source><year>1998</year><volume>3</volume><fpage>D781</fpage><lpage>D794</lpage><comment>Review article highlighting the functions of the <italic>Fgfrs</italic> with a focus on roles in skeletal development.</comment><pub-id pub-id-type="pmid">9683641</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>G</given-names></name><name><surname>Fukabori</surname><given-names>Y</given-names></name><name><surname>McBride</surname><given-names>G</given-names></name><name><surname>Nikolaropolous</surname><given-names>S</given-names></name><name><surname>McKeehan</surname><given-names>WL</given-names></name></person-group><article-title>Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy.</article-title><source>Mol Cell Biol</source><year>1993</year><volume>13</volume><fpage>4513</fpage><lpage>4522</lpage><comment>Demonstration that tumor progression can be accompanied by a change in <italic>Fgfr</italic> alternative splicing with consequent change in ligand binding specificity.</comment><pub-id pub-id-type="pmid">7687739</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orr-Urtreger</surname><given-names>A</given-names></name><name><surname>Bedford</surname><given-names>MT</given-names></name><name><surname>Burakova</surname><given-names>T</given-names></name><name><surname>Arman</surname><given-names>E</given-names></name><name><surname>Zimmer</surname><given-names>Y</given-names></name><name><surname>Yayon</surname><given-names>A</given-names></name><name><surname>Givol</surname><given-names>D</given-names></name><name><surname>Lonai</surname><given-names>P</given-names></name></person-group><article-title>Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2).</article-title><source>Dev Biol</source><year>1993</year><volume>158</volume><fpage>475</fpage><lpage>486</lpage><comment>Demonstration that alternative <italic>Fgfr</italic> splice forms are expressed preferentially in epithelial and mesenchymal lineages.</comment><pub-id pub-id-type="pmid">8393815</pub-id><pub-id pub-id-type="doi">10.1006/dbio.1993.1205</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>E</given-names></name><name><surname>Del Gatto</surname><given-names>F</given-names></name><name><surname>Champion-Arnaud</surname><given-names>P</given-names></name><name><surname>Gesnel</surname><given-names>MC</given-names></name><name><surname>Breathnach</surname><given-names>R</given-names></name></person-group><article-title>Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA.</article-title><source>Mol Cell Biol</source><year>1993</year><volume>13</volume><fpage>5461</fpage><lpage>5468</lpage><comment>Identification of the mechanism regulating tissue-specific usage of alternative splice forms of <italic>Fgfr2</italic>.</comment><pub-id pub-id-type="pmid">8355693</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Avivi</surname><given-names>A</given-names></name><name><surname>Yayon</surname><given-names>A</given-names></name><name><surname>Givol</surname><given-names>D</given-names></name></person-group><article-title>A novel form of FGF receptor-3 using an alternative exon in the immunoglobulin domain III.</article-title><source>FEBS Lett</source><year>1993</year><volume>330</volume><fpage>249</fpage><lpage>252</lpage><comment>Identification of alternative splice forms of <italic>Fgfr3</italic>.</comment><pub-id pub-id-type="pmid">8375495</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scotet</surname><given-names>E</given-names></name><name><surname>Houssaint</surname><given-names>E</given-names></name></person-group><article-title>The choice between alternative IIIb and IIIc exons of the FGFR-3 gene is not strictly tissue-specific.</article-title><source>Biochim Biophys Acta</source><year>1995</year><volume>1264</volume><fpage>238</fpage><lpage>242</lpage><comment>The less stringent alternative splicing choice between exons IIIb and IIIc of FGFR3 is in contrast with the very tissue-specific alternative splicing observed for FGFR2 in which epithelial cells use only the IIIb exon and fibroblasts use only the IIIc exon.</comment><pub-id pub-id-type="pmid">7495869</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ornitz</surname><given-names>DM</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Colvin</surname><given-names>JS</given-names></name><name><surname>McEwen</surname><given-names>DG</given-names></name><name><surname>MacArthur</surname><given-names>CA</given-names></name><name><surname>Coulier</surname><given-names>F</given-names></name><name><surname>Gao</surname><given-names>G</given-names></name><name><surname>Goldfarb</surname><given-names>M</given-names></name></person-group><article-title>Receptor specificity of the fibroblast growth factor family.</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>15292</fpage><lpage>15297</lpage><comment>The first comparison of the relative mitogenic activity of a large number of FGFs on cells expressing a single alternatively spliced FGFR 1-3 or FGFR4.</comment><pub-id pub-id-type="pmid">8663044</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Igarashi</surname><given-names>M</given-names></name><name><surname>Finch</surname><given-names>PW</given-names></name><name><surname>Aaronson</surname><given-names>SA</given-names></name></person-group><article-title>Characterization of recombinant human fibroblast growth factor (Fgf-10) reveals functional similarities with keratinocyte growth factor (Fgf-7).</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>13230</fpage><lpage>13235</lpage><comment>Demonstrates that the receptor-binding specificity of FGF10 is similar to that of the closely related FGF7.</comment><pub-id pub-id-type="pmid">9582367</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miki</surname><given-names>T</given-names></name><name><surname>Fleming</surname><given-names>TP</given-names></name><name><surname>Bottaro</surname><given-names>DP</given-names></name><name><surname>Rubin</surname><given-names>JS</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Aaronson</surname><given-names>SA</given-names></name></person-group><article-title>Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop.</article-title><source>Science</source><year>1991</year><volume>251</volume><fpage>72</fpage><lpage>75</lpage><comment>First cloning of a receptor for FGF7/KGF.</comment><pub-id pub-id-type="pmid">1846048</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacArthur</surname><given-names>CA</given-names></name><name><surname>Lawsh&#x000e9;</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Santos-Ocampo</surname><given-names>S</given-names></name><name><surname>Heikinheimo</surname><given-names>M</given-names></name><name><surname>Chellaiah</surname><given-names>AT</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development.</article-title><source>Development</source><year>1995</year><volume>121</volume><fpage>3603</fpage><lpage>3613</lpage><comment>Identification of alternatively spliced forms of FGF8 and demonstration that these molecules bind the mesenchymal splice forms of <italic>Fgfr2</italic>.</comment><pub-id pub-id-type="pmid">8582274</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heikinheimo</surname><given-names>M</given-names></name><name><surname>Lawsh&#x000e9;</surname><given-names>A</given-names></name><name><surname>Shackleford</surname><given-names>GM</given-names></name><name><surname>Wilson</surname><given-names>DB</given-names></name><name><surname>MacArthur</surname><given-names>CA</given-names></name></person-group><article-title><italic>Fgf-8</italic> expression in the post-gastrulation mouse suggests roles in the development of the face, limbs and central nervous system.</article-title><source>Mech Dev</source><year>1994</year><volume>48</volume><fpage>129</fpage><lpage>138</lpage><comment>Identification of temporal and spatial patterns of <italic>Fgf8</italic> expression in the developing mouse.</comment><pub-id pub-id-type="pmid">7873403</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crossley</surname><given-names>PH</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><article-title>The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo.</article-title><source>Development</source><year>1995</year><volume>121</volume><fpage>439</fpage><lpage>451</lpage><comment>Identification of alternative splice forms of <italic>Fgf8</italic> and <italic>Fgf8</italic> expression in the apical ectodermal ridge.</comment><pub-id pub-id-type="pmid">7768185</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moscatelli</surname><given-names>D</given-names></name></person-group><article-title>High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells.</article-title><source>J Cell Physiol</source><year>1987</year><volume>131</volume><fpage>123</fpage><lpage>130</lpage><comment>This paper challenges the role of cell surface heparan sulfate in FGFR activation but establishes a role for cell surface heparan sulfate in binding FGF.</comment><pub-id pub-id-type="pmid">3032990</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flaumenhaft</surname><given-names>R</given-names></name><name><surname>Moscatelli</surname><given-names>D</given-names></name><name><surname>Rifkin</surname><given-names>DB</given-names></name></person-group><article-title>Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor.</article-title><source>J Cell Biol</source><year>1990</year><volume>111</volume><fpage>1651</fpage><lpage>1659</lpage><comment>This paper demonstrates that the extracellular matrix can store FGF and limit its diffusion in tissues.</comment><pub-id pub-id-type="pmid">2170425</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mach</surname><given-names>H</given-names></name><name><surname>Volkin</surname><given-names>DB</given-names></name><name><surname>Burke</surname><given-names>CJ</given-names></name><name><surname>Middaugh</surname><given-names>CR</given-names></name><name><surname>Linhardt</surname><given-names>RJ</given-names></name><name><surname>Fromm</surname><given-names>JR</given-names></name><name><surname>Loganathan</surname><given-names>D</given-names></name><name><surname>Mattsson</surname><given-names>L</given-names></name></person-group><article-title>Nature of the interaction of heparin with acidic fibroblast growth factor.</article-title><source>Biochemistry</source><year>1993</year><volume>32</volume><fpage>5480</fpage><lpage>5489</lpage><comment>This paper establishes that FGF1 binds heparin at high density (one molecule every 4-5 saccharide units) and with high affinity (50-140 nM).</comment><pub-id pub-id-type="pmid">7684608</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herr</surname><given-names>AB</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name><name><surname>Sasisekharan</surname><given-names>R</given-names></name><name><surname>Venkataraman</surname><given-names>G</given-names></name><name><surname>Waksman</surname><given-names>G</given-names></name></person-group><article-title>Heparin-induced self-association of fibroblast growth factor-2. Evidence for two oligomerization processes.</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>16382</fpage><lpage>16389</lpage><comment>Presents analytical data that indicates that biologically active heparin octasaccharides can induce a monomer-dimer-tetramer assembly of FGF2.</comment><pub-id pub-id-type="pmid">9195945</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moy</surname><given-names>FJ</given-names></name><name><surname>Safran</surname><given-names>M</given-names></name><name><surname>Seddon</surname><given-names>AP</given-names></name><name><surname>Kitchen</surname><given-names>D</given-names></name><name><surname>Bohlen</surname><given-names>P</given-names></name><name><surname>Aviezer</surname><given-names>D</given-names></name><name><surname>Yayon</surname><given-names>A</given-names></name><name><surname>Powers</surname><given-names>R</given-names></name></person-group><article-title>Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.</article-title><source>Biochemistry</source><year>1997</year><volume>36</volume><fpage>4782</fpage><lpage>4791</lpage><comment>Evidence that a <italic>cis</italic>-oriented FGF2 dimer is the minimal biologically active structural unit of FGF2 in the presence of a decasaccharide.</comment><pub-id pub-id-type="pmid">9125499</pub-id><pub-id pub-id-type="doi">10.1021/bi9625455</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ornitz</surname><given-names>DM</given-names></name><name><surname>Yayon</surname><given-names>A</given-names></name><name><surname>Flanagan</surname><given-names>JG</given-names></name><name><surname>Svahn</surname><given-names>CM</given-names></name><name><surname>Levi</surname><given-names>E</given-names></name><name><surname>Leder</surname><given-names>P</given-names></name></person-group><article-title>Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells.</article-title><source>Mol Cell Biol</source><year>1992</year><volume>12</volume><fpage>240</fpage><lpage>247</lpage><comment>First study to show that heparin, FGF and an FGF receptor binding domain form a trimolecular complex <italic>in vitro</italic>. This paper also shows that this complex is essential for receptor activation on cells lacking heparan sulfate proteoglycan.</comment><pub-id pub-id-type="pmid">1309590</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rapraeger</surname><given-names>AC</given-names></name><name><surname>Krufka</surname><given-names>A</given-names></name><name><surname>Olwin</surname><given-names>BB</given-names></name></person-group><article-title>Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.</article-title><source>Science</source><year>1991</year><volume>252</volume><fpage>1705</fpage><lpage>1708</lpage><comment>The first study to demonstrate that cell surface heparan sulfate is directly involved in FGF cell signaling.</comment><pub-id pub-id-type="pmid">1646484</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yayon</surname><given-names>A</given-names></name><name><surname>Klagsbrun</surname><given-names>M</given-names></name><name><surname>Esko</surname><given-names>JD</given-names></name><name><surname>Leder</surname><given-names>P</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.</article-title><source>Cell</source><year>1991</year><volume>64</volume><fpage>841</fpage><lpage>848</lpage><comment>The first study to demonstrate that heparin is required for FGF to bind to an FGF receptor.</comment><pub-id pub-id-type="pmid">1847668</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>XH</given-names></name><name><surname>Buff</surname><given-names>EM</given-names></name><name><surname>Perrimon</surname><given-names>N</given-names></name><name><surname>Michelson</surname><given-names>AM</given-names></name></person-group><article-title>Heparan sulfate proteoglycans are essential for FGF receptor signaling during <italic>Drosophila</italic> embryonic development.</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>3715</fpage><lpage>3723</lpage><comment>The first genetic evidence that heparan sulfate glycosaminoglycans are essential for fibroblast growth factor receptor signaling in a well defined developmental context. These data support the model in which heparan sulfate facilitates FGF and/or FGF-FGFR oligomerization.</comment><pub-id pub-id-type="pmid">10433902</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szebenyi</surname><given-names>G</given-names></name><name><surname>Fallon</surname><given-names>JF</given-names></name></person-group><article-title>Fibroblast growth factors as multifunctional signaling factors.</article-title><source>Int Rev Cytol</source><year>1999</year><volume>185</volume><fpage>45</fpage><lpage>106</lpage><comment>This is a comprehensive review that highlights all aspects of FGF biology including cell signaling, receptor binding and activation and roles for FGFs in embryonic development.</comment><pub-id pub-id-type="pmid">9750265</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schlessinger</surname><given-names>J</given-names></name><name><surname>Plotnikov</surname><given-names>AN</given-names></name><name><surname>Ibrahimi</surname><given-names>OA</given-names></name><name><surname>Eliseenkova</surname><given-names>AV</given-names></name><name><surname>Yeh</surname><given-names>BK</given-names></name><name><surname>Yayon</surname><given-names>A</given-names></name><name><surname>Linhardt</surname><given-names>RJ</given-names></name><name><surname>Mohammadi</surname><given-names>M</given-names></name></person-group><article-title>Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.</article-title><source>Mol Cell</source><year>2000</year><volume>6</volume><fpage>743</fpage><lpage>750</lpage><comment>This paper presents a diffusion-based crystal structure which shows heparan fragments bound to both FGF and the FGFR in a head-to-head orientation.</comment><pub-id pub-id-type="pmid">11030354</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chellaiah</surname><given-names>A</given-names></name><name><surname>Yuan</surname><given-names>W</given-names></name><name><surname>Chellaiah</surname><given-names>M</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity.</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>34785</fpage><lpage>34794</lpage><comment>Identification of a second ligand-binding region on the FGF receptor.</comment><pub-id pub-id-type="pmid">10574949</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meyers</surname><given-names>EN</given-names></name><name><surname>Lewandoski</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><article-title>An <italic>Fgf8</italic> mutant allelic series generated by Cre- and Flp-mediated recombination.</article-title><source>Nat Genet</source><year>1998</year><volume>18</volume><fpage>136</fpage><lpage>141</lpage><comment>First null, hypomorphic and conditional allele created for an FGF. This study reveals requirements for <italic>Fgf8</italic> during gastrulation, cardiac, craniofacial, forebrain, midbrain and cerebellar development.</comment><pub-id pub-id-type="pmid">9462741</pub-id></citation></ref><ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>AM</given-names></name><name><surname>Capecchi</surname><given-names>MR</given-names></name></person-group><article-title>Fgf8 is required for outgrowth and patterning of the limbs.</article-title><source>Nat Genet</source><year>2000</year><volume>26</volume><fpage>455</fpage><lpage>459</lpage><comment>Demonstrates an essential role for <italic>Fgf8</italic> in limb bud development.</comment><pub-id pub-id-type="pmid">11101845</pub-id><pub-id pub-id-type="doi">10.1038/82601</pub-id></citation></ref><ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewandoski</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><article-title>Fgf8 signalling from the AER is essential for normal limb development.</article-title><source>Nat Genet</source><year>2000</year><volume>26</volume><fpage>460</fpage><lpage>463</lpage><comment>Demonstrates an essential role for <italic>Fgf8</italic> in limb bud development.</comment><pub-id pub-id-type="pmid">11101846</pub-id><pub-id pub-id-type="doi">10.1038/82609</pub-id></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reifers</surname><given-names>F</given-names></name><name><surname>Bohli</surname><given-names>H</given-names></name><name><surname>Walsh</surname><given-names>EC</given-names></name><name><surname>Crossley</surname><given-names>PH</given-names></name><name><surname>Stainier</surname><given-names>DY</given-names></name><name><surname>Brand</surname><given-names>M</given-names></name></person-group><article-title><italic>Fgf8</italic> is mutated in zebrafish <italic>acerebellar</italic> (<italic>ace</italic>) mutants and is required for maintenance of midbrain-hindbrain boundary development and somitogenesis.</article-title><source>Development</source><year>1998</year><volume>125</volume><fpage>2381</fpage><lpage>2395</lpage><comment>Demonstrates a role for <italic>Fgf8</italic> in midbrain hindbrain development in zebrafish by demonstrating genetic linkage between <italic>Fgf8</italic> and the <italic>acerebellar</italic> (<italic>ace</italic>) mutation. Demonstrates that <italic>ace</italic> is probably a null mutation in <italic>Fgf8</italic>.</comment><pub-id pub-id-type="pmid">9609821</pub-id></citation></ref><ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heisenberg</surname><given-names>CP</given-names></name><name><surname>Brennan</surname><given-names>C</given-names></name><name><surname>Wilson</surname><given-names>SW</given-names></name></person-group><article-title>Zebrafish aussicht mutant embryos exhibit widespread overexpression of ace (fgf8) and coincident defects in CNS development.</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>2129</fpage><lpage>2140</lpage><comment>Identification of a genetic locus that may regulate <italic>Fgf8 (ace)</italic> expression in zebrafish.</comment><pub-id pub-id-type="pmid">10207138</pub-id></citation></ref><ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hebert</surname><given-names>JM</given-names></name><name><surname>Rosenquist</surname><given-names>T</given-names></name><name><surname>Gotz</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><article-title>FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations.</article-title><source>Cell</source><year>1994</year><volume>78</volume><fpage>1017</fpage><lpage>1025</lpage><comment>Demonstrates that a null allele in the <italic>Fgf5</italic> gene is allelic with the mouse <italic>angora</italic> mutation. Identifies an essential role for FGF5 in regulating the hair growth cycle.</comment><pub-id pub-id-type="pmid">7923352</pub-id></citation></ref><ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carlton</surname><given-names>MBL</given-names></name><name><surname>Colledge</surname><given-names>WH</given-names></name><name><surname>Evans</surname><given-names>MJ</given-names></name></person-group><article-title>Crouzon-like craniofacial dysmorphology in the mouse is caused by an insertional mutation at the Fgf3/Fgf4 locus.</article-title><source>Dev Dyn</source><year>1998</year><volume>212</volume><fpage>242</fpage><lpage>249</lpage><comment>Identification of a retroviral integration in the intragenic region between <italic>Fgf3</italic> and <italic>Fgf4</italic> in the Bulgy-eye (Bey) mutant mouse. Expression of both <italic>Fgf3</italic> and <italic>Fgf4</italic> is up-regulated in the cranial sutures of Bey mice. Phenocopies some features of Crouzon syndrome.</comment><pub-id pub-id-type="pmid">9626498</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-0177(199806)212:2&#x0003c;242::AID-AJA8&#x0003e;3.3.CO;2-Z</pub-id></citation></ref><ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>KE</given-names></name><name><surname>Evans</surname><given-names>WE</given-names></name><name><surname>O'Riordan</surname><given-names>JL</given-names></name><name><surname>Speer</surname><given-names>MC</given-names></name><name><surname>Econs</surname><given-names>MJ</given-names></name><name><surname>Lorenz-Depiereux</surname><given-names>B</given-names></name><name><surname>Grabowski</surname><given-names>M</given-names></name><name><surname>Meitinger</surname><given-names>T</given-names></name><name><surname>Strom</surname><given-names>TM</given-names></name></person-group><article-title>Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.</article-title><source>Nat Genet</source><year>2000</year><volume>26</volume><fpage>345</fpage><lpage>348</lpage><comment>First identification of a missense mutation in an FGF ligand in a human genetic disease. Autosomal dominant hypophosphataemic rickets (ADHR) is characterized by low serum phosphorus concentrations, rickets, osteomalacia, lower extremity deformities, short stature, bone pain and dental abscesses.</comment><pub-id pub-id-type="pmid">11062477</pub-id><pub-id pub-id-type="doi">10.1038/81664</pub-id></citation></ref><ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>KE</given-names></name><name><surname>Jonsson</surname><given-names>KB</given-names></name><name><surname>Carn</surname><given-names>G</given-names></name><name><surname>Hampson</surname><given-names>G</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Mannstadt</surname><given-names>M</given-names></name><name><surname>Lorenz-Depiereux</surname><given-names>B</given-names></name><name><surname>Miyauchi</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>IM</given-names></name><name><surname>Ljunggren</surname><given-names>O</given-names></name><etal></etal></person-group><article-title>The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting.</article-title><source>J Clin Endocrinol Metab</source><year>2001</year><volume>86</volume><fpage>497</fpage><lpage>500</lpage><comment>FGF-23, the gene mutated in ADHR, is a secreted protein and its mRNA is abundantly expressed by several different oncogenic hypophosphatemic osteomalacia tumors.</comment><pub-id pub-id-type="pmid">11157998</pub-id></citation></ref><ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gecz</surname><given-names>J</given-names></name><name><surname>Baker</surname><given-names>E</given-names></name><name><surname>Donnelly</surname><given-names>A</given-names></name><name><surname>Ming</surname><given-names>JE</given-names></name><name><surname>McDonald-McGinn</surname><given-names>DM</given-names></name><name><surname>Spinner</surname><given-names>NB</given-names></name><name><surname>Zackai</surname><given-names>EH</given-names></name><name><surname>Sutherland</surname><given-names>GR</given-names></name><name><surname>Mulley</surname><given-names>JC</given-names></name></person-group><article-title>Fibroblast growth factor homologous factor 2 (FHF2): gene structure, expression and mapping to the Borjeson-Forssman-Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS-like patient.</article-title><source>Hum Genet</source><year>1999</year><volume>104</volume><fpage>56</fpage><lpage>63</lpage><comment>Identification of linkage between FGF12/FHF2 and Borjeson-Forssman-Lehmann syndrome.</comment><pub-id pub-id-type="pmid">10071193</pub-id><pub-id pub-id-type="doi">10.1007/s004390050910</pub-id></citation></ref><ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Z</given-names></name><name><surname>Meyer</surname><given-names>K</given-names></name><name><surname>Rapraeger</surname><given-names>AC</given-names></name><name><surname>Friedl</surname><given-names>A</given-names></name></person-group><article-title>Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ.</article-title><source>FASEB J</source><year>2000</year><volume>14</volume><fpage>137</fpage><lpage>144</lpage><comment>First paper to demonstrate that tissue-specific heparan sulfate molecules can affect patterns of FGF and FGF receptor binding <italic>in situ</italic>.</comment><pub-id pub-id-type="pmid">10627288</pub-id></citation></ref><ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Madiai</surname><given-names>F</given-names></name><name><surname>Hackshaw</surname><given-names>KV</given-names></name><name><surname>Chiu</surname><given-names>IM</given-names></name></person-group><article-title>Characterization of the entire transcription unit of the mouse fibroblast growth factor 1 (FGF-1) gene. Tissue-specific expression of the FGF-1.A mRNA.</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>11937</fpage><lpage>11944</lpage><comment>This paper defines the entire transcriptional unit of the mouse Fgf1 gene and shows that heart is the most abundant source of Fgf1.A mRNA.</comment><pub-id pub-id-type="pmid">10207015</pub-id></citation></ref><ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>JA</given-names></name><name><surname>Whang</surname><given-names>JL</given-names></name><name><surname>Tumolo</surname><given-names>A</given-names></name><name><surname>Mergia</surname><given-names>A</given-names></name><name><surname>Friedman</surname><given-names>J</given-names></name><name><surname>Gospodarowicz</surname><given-names>D</given-names></name><name><surname>Fiddes</surname><given-names>JC</given-names></name></person-group><article-title>Human basic fibroblast growth factor: nucleotide sequence and genomic organization.</article-title><source>EMBO J</source><year>1986</year><volume>5</volume><fpage>2523</fpage><lpage>2528</lpage><comment>First cloned member of the FGF family.</comment><pub-id pub-id-type="pmid">3780670</pub-id></citation></ref><ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brookes</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>R</given-names></name><name><surname>Thurlow</surname><given-names>J</given-names></name><name><surname>Dickson</surname><given-names>C</given-names></name><name><surname>Peters</surname><given-names>G</given-names></name></person-group><article-title>The mouse homologue of hst/k-FGF: sequence, genome organization and location relative to int-2.</article-title><source>Nucleic Acids Res</source><year>1989</year><volume>17</volume><fpage>4037</fpage><lpage>4045</lpage><comment>This paper idenitifies the mouse <italic>Fgf4</italic> gene and shows that it is within 20 kb of the <italic>Fgf3</italic> gene on chromosome 7.</comment><pub-id pub-id-type="pmid">2740210</pub-id></citation></ref><ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colvin</surname><given-names>JS</given-names></name><name><surname>Feldman</surname><given-names>B</given-names></name><name><surname>Nadeau</surname><given-names>JH</given-names></name><name><surname>Goldfarb</surname><given-names>M</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>Genomic organization and embryonic expression of the mouse fibroblast growth factor 9 gene.</article-title><source>Dev Dyn</source><year>1999</year><volume>216</volume><fpage>72</fpage><lpage>88</lpage><comment>Contains a detailed analysis of the embryonic expression patterns of <italic>Fgf9</italic>.</comment><pub-id pub-id-type="pmid">10474167</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-0177(199909)216:1&#x0003c;72::AID-DVDY9&#x0003e;3.3.CO;2-0</pub-id></citation></ref><ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>IM</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Payson</surname><given-names>RA</given-names></name></person-group><article-title>Isolation of yeast artificial chromosomes containing the entire transcriptional unit of the human FGF1 gene: a 720-kb contig spanning human chromosome 5q31.3-&#x0003e;q32.</article-title><source>Cancer Genet Cytogenet</source><year>1998</year><volume>106</volume><fpage>1</fpage><lpage>10</lpage><comment>Localization of the <italic>Fgf1</italic> gene to the q31-q33 region of chromosome 5, a regions that includes a number of genes encoding growth factors, growth factor receptors, hormone/neurotransmitter receptors.</comment><pub-id pub-id-type="pmid">9772902</pub-id></citation></ref><ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>RD</given-names></name><name><surname>Copeland</surname><given-names>NG</given-names></name><name><surname>Jenkins</surname><given-names>NA</given-names></name><name><surname>Lehrach</surname><given-names>H</given-names></name></person-group><article-title>Interspersed repetitive element polymerase chain reaction product mapping using a mouse interspecific backcross.</article-title><source>Genomics</source><year>1991</year><volume>10</volume><fpage>375</fpage><lpage>384</lpage><comment>A rapid method to generate and map inter-repeat polymerase chain reaction products using DNA from interspecific backcross mice.</comment><pub-id pub-id-type="pmid">2071145</pub-id></citation></ref><ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lafage-Pochitaloff</surname><given-names>M</given-names></name><name><surname>Galland</surname><given-names>F</given-names></name><name><surname>Simonetti</surname><given-names>J</given-names></name><name><surname>Prats</surname><given-names>H</given-names></name><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name></person-group><article-title>The human basic fibroblast growth factor gene is located on the long arm of chromosome 4 at bands q26-q27.</article-title><source>Oncogene Res</source><year>1990</year><volume>5</volume><fpage>241</fpage><lpage>244</lpage><comment>Chromosomal localization of human FGF2.</comment><pub-id pub-id-type="pmid">2320377</pub-id></citation></ref><ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>Pebusque</surname><given-names>MJ</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name></person-group><article-title>Chromosomal localizations of mouse Fgf2 and Fgf5 genes.</article-title><source>Mamm Genome</source><year>1992</year><volume>2</volume><fpage>135</fpage><lpage>137</lpage><comment>Mapping of <italic>Fgf2</italic> and <italic>Fgf5</italic> on mouse chromosome 4.</comment><pub-id pub-id-type="pmid">1543906</pub-id></citation></ref><ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Crow</surname><given-names>TJ</given-names></name></person-group><article-title>Human proto-oncogene Int-2/FGF-3 map position 11q13.3-q13.4.</article-title><source>Chromosome Res</source><year>1998</year><volume>6</volume><fpage>579</fpage><comment>Chromosomal localization of human <italic>FGF3.</italic></comment><pub-id pub-id-type="pmid">9886778</pub-id></citation></ref><ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>CM</given-names></name><name><surname>Wada</surname><given-names>M</given-names></name><name><surname>Satoh</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Sakamoto</surname><given-names>H</given-names></name><name><surname>Miyagawa</surname><given-names>K</given-names></name><name><surname>Yokota</surname><given-names>J</given-names></name><name><surname>Koda</surname><given-names>T</given-names></name><name><surname>Kakinuma</surname><given-names>M</given-names></name><name><surname>Sugimura</surname><given-names>T</given-names></name><etal></etal></person-group><article-title>Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the Int2 gene in human cancer.</article-title><source>Proc Natl Acad Sci USA</source><year>1988</year><volume>85</volume><fpage>4861</fpage><lpage>4864</lpage><comment>Mapping of human <italic>FGF4</italic> to chromosome 11q13. Both <italic>FGF3</italic> and <italic>FGF4</italic> were co-amplified in DNA from a stomach cancer and a vulvar carcinoma cell line.</comment><pub-id pub-id-type="pmid">3290903</pub-id></citation></ref><ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>G</given-names></name><name><surname>Kozak</surname><given-names>C</given-names></name><name><surname>Dickson</surname><given-names>C</given-names></name></person-group><article-title>Mouse mammary tumor virus integration regions int-1 and int-2 map on different mouse chromosomes.</article-title><source>Mol Cell Biol</source><year>1984</year><volume>4</volume><fpage>375</fpage><lpage>378</lpage><comment>Demonstration that MMTV can activate expression of FGF3 to initiate oncogenesis in mouse mammary epithelial cells.</comment><pub-id pub-id-type="pmid">6321961</pub-id></citation></ref><ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>G</given-names></name><name><surname>Brookes</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>R</given-names></name><name><surname>Placzek</surname><given-names>M</given-names></name><name><surname>Dickson</surname><given-names>C</given-names></name></person-group><article-title>The mouse homolog of the <italic>hst/k-FGF</italic> gene is adjacent to <italic>int-2</italic> and is activated by proviral insertion in some virally induced mammary tumors.</article-title><source>Proc Natl Acad Sci USA</source><year>1989</year><volume>86</volume><fpage>5678</fpage><lpage>5682</lpage><comment>Identification of a close linkage between <italic>Fgf3</italic> and <italic>Fgf4</italic> on mouse chromosome 7. Demonstration that either or both <italic>Fgf3</italic> and <italic>Fgf4</italic> can be activated by mouse mammary tumor virus integration.</comment><pub-id pub-id-type="pmid">2548184</pub-id></citation></ref><ref id="B90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>C</given-names></name><name><surname>Roux</surname><given-names>D</given-names></name><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>de Lapeyriere</surname><given-names>O</given-names></name><name><surname>Goldfarb</surname><given-names>M</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name><name><surname>Jordan</surname><given-names>BR</given-names></name></person-group><article-title>The FGF-related oncogenes hst and int.2, and the bcl.1 locus are contained within one megabase in band q13 of chromosome 11, while the fgf.5 oncogene maps to 4q21.</article-title><source>Oncogene</source><year>1988</year><volume>3</volume><fpage>703</fpage><lpage>708</lpage><comment>Identification of physical linkage between <italic>Fgf3</italic> and <italic>Fgf4</italic> on human chromosome 11.</comment><pub-id pub-id-type="pmid">2577873</pub-id></citation></ref><ref id="B91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>deLapeyriere</surname><given-names>O</given-names></name><name><surname>Rosnet</surname><given-names>O</given-names></name><name><surname>Benharroch</surname><given-names>D</given-names></name><name><surname>Raybaud</surname><given-names>F</given-names></name><name><surname>Marchetto</surname><given-names>S</given-names></name><name><surname>Planche</surname><given-names>J</given-names></name><name><surname>Galland</surname><given-names>F</given-names></name><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>Copeland</surname><given-names>NG</given-names></name><name><surname>Jenkins</surname><given-names>NA</given-names></name><etal></etal></person-group><article-title>Structure, chromosome mapping and expression of the murine Fgf-6 gene.</article-title><source>Oncogene</source><year>1990</year><volume>5</volume><fpage>823</fpage><lpage>831</lpage><comment>Localization of <italic>Fgf6</italic> on mouse chromosome 6.</comment><pub-id pub-id-type="pmid">2193291</pub-id></citation></ref><ref id="B92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marics</surname><given-names>I</given-names></name><name><surname>Adelaide</surname><given-names>J</given-names></name><name><surname>Raybaud</surname><given-names>F</given-names></name><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>Coulier</surname><given-names>F</given-names></name><name><surname>Planche</surname><given-names>J</given-names></name><name><surname>de Lapeyriere</surname><given-names>O</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name></person-group><article-title>Characterization of the HST-related FGF.6 gene, a new member of the fibroblast growth factor gene family.</article-title><source>Oncogene</source><year>1989</year><volume>4</volume><fpage>335</fpage><lpage>340</lpage><comment>Cloning of <italic>FGF6</italic> based on sequence similarity with <italic>FGF4</italic>. <italic>FGF6</italic> was mapped to chromosome 12p13.</comment><pub-id pub-id-type="pmid">2649847</pub-id></citation></ref><ref id="B93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zimonjic</surname><given-names>DB</given-names></name><name><surname>Kelley</surname><given-names>MJ</given-names></name><name><surname>Rubin</surname><given-names>JS</given-names></name><name><surname>Aaronson</surname><given-names>SA</given-names></name><name><surname>Popescu</surname><given-names>NC</given-names></name></person-group><article-title>Fluorescence in situ hybridization analysis of keratinocyte growth factor gene amplification and dispersion in evolution of great apes and humans.</article-title><source>Proc Natl Acad Sci USA</source><year>1997</year><volume>94</volume><fpage>11461</fpage><lpage>11465</lpage><comment>Chromosomal localization of <italic>Fgf7</italic> sequences in human and great ape genomes indicates that amplification and dispersion occurred in multiple discrete steps during evolution.</comment><pub-id pub-id-type="pmid">9326632</pub-id></citation></ref><ref id="B94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>deLapeyriere</surname><given-names>O</given-names></name><name><surname>Bresnick</surname><given-names>J</given-names></name><name><surname>Dickson</surname><given-names>C</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name><name><surname>Mason</surname><given-names>I</given-names></name></person-group><article-title>Mouse Fgf7 (fibroblast growth factor 7) and Fgf8 (fibroblast growth factor 8) genes map to chromosomes 2 and 19 respectively.</article-title><source>Mamm Genome</source><year>1995</year><volume>6</volume><fpage>196</fpage><lpage>197</lpage><comment>Mouse <italic>Fgf7</italic> and <italic>Fgf8</italic> genes were mapped to chromosomes 2F-G and 19C3-D, respectively.</comment><pub-id pub-id-type="pmid">7749227</pub-id></citation></ref><ref id="B95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Payson</surname><given-names>RA</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Chiu</surname><given-names>IM</given-names></name></person-group><article-title>The human Fgf-8 gene localizes on chromosome 10q24 and is subjected to induction by androgen in breast cancer cells.</article-title><source>Oncogene</source><year>1996</year><volume>13</volume><fpage>47</fpage><lpage>53</lpage><comment>Mapping human <italic>FGF8</italic> to chromosome 1Oq24.</comment><pub-id pub-id-type="pmid">8700553</pub-id></citation></ref><ref id="B96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>Penault-Llorca</surname><given-names>F</given-names></name><name><surname>Coulier</surname><given-names>F</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name></person-group><article-title>The human FGF9 gene maps to chromosomal region 13q11-q12.</article-title><source>Genomics</source><year>1995</year><volume>29</volume><fpage>811</fpage><lpage>812</lpage><comment>Chromosomal localization of human <italic>FGF9</italic> to 13q11-q12.</comment><pub-id pub-id-type="pmid">8575785</pub-id><pub-id pub-id-type="doi">10.1006/geno.1995.9926</pub-id></citation></ref><ref id="B97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>De Moerlooze</surname><given-names>L</given-names></name><name><surname>Lovec</surname><given-names>H</given-names></name><name><surname>Coulier</surname><given-names>F</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name><name><surname>Dickson</surname><given-names>C</given-names></name></person-group><article-title>Mouse fgf9 (fibroblast growth factor 9) is localized on chromosome 14.</article-title><source>Mamm Genome</source><year>1997</year><volume>8</volume><fpage>617</fpage><lpage>618</lpage><pub-id pub-id-type="pmid">9250873</pub-id></citation></ref><ref id="B98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Emoto</surname><given-names>H</given-names></name><name><surname>Tagashira</surname><given-names>S</given-names></name><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>Yamasaki</surname><given-names>M</given-names></name><name><surname>Hashimoto</surname><given-names>G</given-names></name><name><surname>Katsumata</surname><given-names>T</given-names></name><name><surname>Negoro</surname><given-names>T</given-names></name><name><surname>Nakatsuka</surname><given-names>M</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name><name><surname>Coulier</surname><given-names>F</given-names></name><etal></etal></person-group><article-title>Structure and expression of human fibroblast growth factor-10.</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>23191</fpage><lpage>23194</lpage><comment>Cloning and mapping of human FGF10 to 5p12-p13. Demonstration that FGF10 is similar to FGF7 in both sequence and biological activity.</comment><pub-id pub-id-type="pmid">9287324</pub-id></citation></ref><ref id="B99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crackower</surname><given-names>MA</given-names></name><name><surname>Heng</surname><given-names>HH</given-names></name><name><surname>Tsui</surname><given-names>LC</given-names></name></person-group><article-title>Assignment of mouse fibroblast growth factor 10 (Fgf10) gene to the telomeric region of chromosome 13.</article-title><source>Genomics</source><year>1998</year><volume>53</volume><fpage>247</fpage><lpage>248</lpage><comment>Mapping <italic>Fgf10</italic> to mouse chromosome 13.</comment><pub-id pub-id-type="pmid">9790778</pub-id><pub-id pub-id-type="doi">10.1006/geno.1998.5506</pub-id></citation></ref><ref id="B100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Verdier</surname><given-names>AS</given-names></name><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>Lovec</surname><given-names>H</given-names></name><name><surname>Hartung</surname><given-names>H</given-names></name><name><surname>Goldfarb</surname><given-names>M</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name><name><surname>Coulier</surname><given-names>F</given-names></name></person-group><article-title>Chromosomal mapping of two novel human FGF genes, FGF11 and FGF12.</article-title><source>Genomics</source><year>1997</year><volume>40</volume><fpage>151</fpage><lpage>154</lpage><comment>Mapping human <italic>FGF11</italic> and <italic>FGF12</italic> to chromosome 17p12-p13 and 3q28, respectively.</comment><pub-id pub-id-type="pmid">9070933</pub-id><pub-id pub-id-type="doi">10.1006/geno.1996.4492</pub-id></citation></ref><ref id="B101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartung</surname><given-names>H</given-names></name><name><surname>Lovec</surname><given-names>H</given-names></name><name><surname>Verdier</surname><given-names>AS</given-names></name><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>Coulier</surname><given-names>F</given-names></name><name><surname>Goldfarb</surname><given-names>M</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name></person-group><article-title>Assignment of Fgf12 to mouse chromosome bands 16B1-&#x0003e;B3 by in situ hybridization.</article-title><source>Cytogenet Cell Genet</source><year>1997</year><volume>76</volume><fpage>185</fpage><lpage>186</lpage><comment>Mapping mouse <italic>Fgf12</italic> to chromosome 13B1-3.</comment><pub-id pub-id-type="pmid">9186519</pub-id></citation></ref><ref id="B102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Chiu</surname><given-names>IM</given-names></name></person-group><article-title>Assignment of Fgf12, the human Fgf homologous factor 1 gene, to chromosome 3q29-&#x0003e;3qter by fluorescence <italic>in situ</italic> hybridization.</article-title><source>Cytogenet Cell Genet</source><year>1997</year><volume>78</volume><fpage>48</fpage><lpage>49</lpage><comment>Mapping human <italic>FGF12</italic> to chromosome 3q29-3qter.</comment><pub-id pub-id-type="pmid">9345906</pub-id></citation></ref><ref id="B103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lovec</surname><given-names>H</given-names></name><name><surname>Hartung</surname><given-names>H</given-names></name><name><surname>Verdier</surname><given-names>AS</given-names></name><name><surname>Mattei</surname><given-names>MG</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name><name><surname>Goldfarb</surname><given-names>M</given-names></name><name><surname>Coulier</surname><given-names>F</given-names></name></person-group><article-title>Assignment of FGF13 to human chromosome band Xq21 by in situ hybridization.</article-title><source>Cytogenet Cell Genet</source><year>1997</year><volume>76</volume><fpage>183</fpage><lpage>184</lpage><comment>Mapping <italic>FGF13</italic> to human chromosome Xq21.</comment><pub-id pub-id-type="pmid">9186518</pub-id></citation></ref><ref id="B104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Lawshe</surname><given-names>A</given-names></name><name><surname>MacArthur</surname><given-names>CA</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>Genomic structure, mapping, activity and expression of fibroblast growth factor 17.</article-title><source>Mech Dev</source><year>1999</year><volume>83</volume><fpage>165</fpage><lpage>78</lpage><comment>Expression patterns of <italic>Fgf17</italic> and <italic>Fgf8</italic> and demonstration that <italic>Fgf17</italic> has similar receptor specificity, genomic organization and alternative splicing to <italic>Fgf8</italic>.</comment><pub-id pub-id-type="pmid">10381577</pub-id></citation></ref><ref id="B105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whitmore</surname><given-names>TE</given-names></name><name><surname>Maurer</surname><given-names>MF</given-names></name><name><surname>Sexson</surname><given-names>S</given-names></name><name><surname>Raymond</surname><given-names>F</given-names></name><name><surname>Conklin</surname><given-names>D</given-names></name><name><surname>Deisher</surname><given-names>TA</given-names></name></person-group><article-title>Assignment of fibroblast growth factor 18 (FGF18) to human chromosome 5q34 by use of radiation hybrid mapping and fluorescence in situ hybridization.</article-title><source>Cytogenet Cell Genet</source><year>2000</year><volume>90</volume><fpage>231</fpage><lpage>233</lpage><comment>Mapping <italic>FGF18</italic> to human chromosome 5q34.</comment><pub-id pub-id-type="pmid">11124520</pub-id></citation></ref><ref id="B106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>MH</given-names></name><name><surname>Holcomb</surname><given-names>I</given-names></name><name><surname>Deuel</surname><given-names>B</given-names></name><name><surname>Dowd</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>A</given-names></name><name><surname>Vagts</surname><given-names>A</given-names></name><name><surname>Foster</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Brush</surname><given-names>J</given-names></name><name><surname>Gu</surname><given-names>Q</given-names></name><etal></etal></person-group><article-title>FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4.</article-title><source>Cytokine</source><year>1999</year><volume>11</volume><fpage>729</fpage><lpage>735</lpage><comment>Identification of human <italic>Fgf19</italic> and demonstration of <italic>in vitro</italic> biological activity.</comment><pub-id pub-id-type="pmid">10525310</pub-id><pub-id pub-id-type="doi">10.1006/cyto.1999.0485</pub-id></citation></ref><ref id="B107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirikoshi</surname><given-names>H</given-names></name><name><surname>Sagara</surname><given-names>N</given-names></name><name><surname>Saitoh</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Sekihara</surname><given-names>H</given-names></name><name><surname>Shiokawa</surname><given-names>K</given-names></name><name><surname>Katoh</surname><given-names>M</given-names></name></person-group><article-title>Molecular cloning and characterization of human FGF-20 on chromosome 8p21.3-p22.</article-title><source>Biochem Biophys Res Commun</source><year>2000</year><volume>274</volume><fpage>337</fpage><lpage>343</lpage><comment>Cloning of human <italic>FGF20</italic> and mapping to chromosome 8p21.3-p22. FGF20 is most closely related to FGF9 and FGF16. <italic>FGF20</italic> mRNA was detected in a colon cancer cell line and at lower levels in human fetal tissues and primary tumors.</comment><pub-id pub-id-type="pmid">10913340</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.2000.3142</pub-id></citation></ref><ref id="B108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Nakatake</surname><given-names>Y</given-names></name><name><surname>Konishi</surname><given-names>M</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name></person-group><article-title>Identification of a novel FGF, FGF-21, preferentially expressed in the liver.</article-title><source>Biochim Biophys Acta</source><year>2000</year><volume>1492</volume><fpage>203</fpage><lpage>206</lpage><comment>Cloning of <italic>Fgf21</italic> an <italic>Fgf</italic> most closely related to <italic>Fgf19</italic> and <italic>Fgf23</italic>.</comment><pub-id pub-id-type="pmid">10858549</pub-id></citation></ref><ref id="B109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakatake</surname><given-names>Y</given-names></name><name><surname>Hoshikawa</surname><given-names>M</given-names></name><name><surname>Asaki</surname><given-names>T</given-names></name><name><surname>Kassai</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name></person-group><article-title>Identification of a novel fibroblast growth factor, FGF-22, preferentially expressed in the inner root sheath of the hair follicle.</article-title><source>Biochim Biophys Acta</source><year>2001</year><volume>1517</volume><fpage>460</fpage><lpage>463</lpage><comment>Identification of <italic>Fgf22</italic>, a homolog of <italic>Fgf7</italic> and <italic>Fgf10</italic>.</comment><pub-id pub-id-type="pmid">11342227</pub-id></citation></ref><ref id="B110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>DL</given-names></name><name><surname>Ortega</surname><given-names>S</given-names></name><name><surname>Bashayan</surname><given-names>O</given-names></name><name><surname>Basch</surname><given-names>R</given-names></name><name><surname>Basilico</surname><given-names>C</given-names></name></person-group><article-title>Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice.</article-title><source>Mol Cell Biol</source><year>2000</year><volume>20</volume><fpage>2260</fpage><lpage>2268</lpage><comment>The relatively mild phenotypic defects associated with loss of FGF2 led to the hypothesis that other FGFs partially compensate. However, FGF1-FGF2 double-knockout mice are viable and fertile and do not display any gross phenotypic defects.Thus <italic>Fgf1</italic> null mice do not have a detectable phenotype and lack redundancy with <italic>Fgf2</italic>.</comment><pub-id pub-id-type="pmid">10688672</pub-id></citation></ref><ref id="B111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tobe</surname><given-names>T</given-names></name><name><surname>Ortega</surname><given-names>S</given-names></name><name><surname>Luna</surname><given-names>JD</given-names></name><name><surname>Ozaki</surname><given-names>H</given-names></name><name><surname>Okamoto</surname><given-names>N</given-names></name><name><surname>Derevjanik</surname><given-names>NL</given-names></name><name><surname>Vinores</surname><given-names>SA</given-names></name><name><surname>Basilico</surname><given-names>C</given-names></name><name><surname>Campochiaro</surname><given-names>PA</given-names></name></person-group><article-title>Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model.</article-title><source>Am J Pathol</source><year>1998</year><volume>153</volume><fpage>1641</fpage><lpage>1646</lpage><comment>This study demonstrates that FGF2 is not required for the development of choroidal neovascularization.</comment><pub-id pub-id-type="pmid">9811357</pub-id></citation></ref><ref id="B112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ortega</surname><given-names>S</given-names></name><name><surname>Ittmann</surname><given-names>M</given-names></name><name><surname>Tsang</surname><given-names>SH</given-names></name><name><surname>Ehrlich</surname><given-names>M</given-names></name><name><surname>Basilico</surname><given-names>C</given-names></name></person-group><article-title>Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2.</article-title><source>Proc Natl Acad Sci, USA</source><year>1998</year><volume>95</volume><fpage>5672</fpage><lpage>5677</lpage><comment>Mice lacking Fgf2 are viable, fertile and phenotypically indistinguishable from wild type. Although not essential for embryonic development, loss of FGF2 leads to defects in cortical neurogenesis and skin wound healing in mice.</comment><pub-id pub-id-type="pmid">9576942</pub-id></citation></ref><ref id="B113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Sutliff</surname><given-names>RL</given-names></name><name><surname>Paul</surname><given-names>RJ</given-names></name><name><surname>Lorenz</surname><given-names>JN</given-names></name><name><surname>Hoying</surname><given-names>JB</given-names></name><name><surname>Haudenschild</surname><given-names>CC</given-names></name><name><surname>Yin</surname><given-names>M</given-names></name><name><surname>Coffin</surname><given-names>JD</given-names></name><name><surname>Kong</surname><given-names>L</given-names></name><name><surname>Kranias</surname><given-names>EG</given-names></name><etal></etal></person-group><article-title>Fibroblast growth factor 2 control of vascular tone.</article-title><source>Nat Med</source><year>1998</year><volume>4</volume><fpage>201</fpage><lpage>207</lpage><comment>Mice lacking Fgf2 are morphologically normal but display decreased vascular smooth muscle contractility, low blood pressure and thrombocytosis.</comment><pub-id pub-id-type="pmid">9461194</pub-id></citation></ref><ref id="B114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schultz</surname><given-names>JE</given-names></name><name><surname>Witt</surname><given-names>SA</given-names></name><name><surname>Nieman</surname><given-names>ML</given-names></name><name><surname>Reiser</surname><given-names>PJ</given-names></name><name><surname>Engle</surname><given-names>SJ</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Pawlowski</surname><given-names>SA</given-names></name><name><surname>Lorenz</surname><given-names>JN</given-names></name><name><surname>Kimball</surname><given-names>TR</given-names></name><name><surname>Doetschman</surname><given-names>T</given-names></name></person-group><article-title>Fibroblast growth factor-2 mediates pressure-induced hypertrophic response.</article-title><source>J Clin Invest</source><year>1999</year><volume>104</volume><fpage>709</fpage><lpage>719</lpage><comment>Identification of a role for FGF2 in the pathogenesis of cardiac hypertrophy.</comment><pub-id pub-id-type="pmid">10491406</pub-id></citation></ref><ref id="B115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mansour</surname><given-names>SL</given-names></name></person-group><article-title>Targeted disruption of int-2 (fgf-3) causes developmental defects in the tail and inner ear.</article-title><source>Mol Reprod Dev</source><year>1994</year><volume>39</volume><fpage>62</fpage><lpage>67</lpage><comment>The first member of the <italic>Fgf</italic> family to be knocked out in mice. Developmental defects were discovered in the inner ear and in outgrowth of the tail.</comment><pub-id pub-id-type="pmid">7999362</pub-id></citation></ref><ref id="B116"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>B</given-names></name><name><surname>Poueymirou</surname><given-names>W</given-names></name><name><surname>Papaioannou</surname><given-names>VE</given-names></name><name><surname>DeChiara</surname><given-names>TM</given-names></name><name><surname>Goldfarb</surname><given-names>M</given-names></name></person-group><article-title>Requirement of FGF-4 for postimplantation mouse development.</article-title><source>Science</source><year>1995</year><volume>267</volume><fpage>246</fpage><lpage>249</lpage><comment><italic>Fgf4</italic> null embryos implant but die shortly thereafter. <italic>Fgf4</italic> null embryos cultured <italic>in vitro</italic> displayed severely impaired proliferation of the inner cell mass.</comment><pub-id pub-id-type="pmid">7809630</pub-id></citation></ref><ref id="B117"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fiore</surname><given-names>F</given-names></name><name><surname>Sebille</surname><given-names>A</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name></person-group><article-title>Skeletal muscle regeneration is not impaired in Fgf6-/- mutant mice.</article-title><source>Biochem Biophys Res Commun</source><year>2000</year><volume>272</volume><fpage>138</fpage><lpage>143</lpage><comment>Mice lacking <italic>Fgf6</italic> have normal muscle regeneration. This is in contrast to the relatively severe phenotype noted by Floss <italic>et al.</italic> [118].</comment><pub-id pub-id-type="pmid">10872817</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.2000.2703</pub-id></citation></ref><ref id="B118"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Floss</surname><given-names>T</given-names></name><name><surname>Arnold</surname><given-names>HH</given-names></name><name><surname>Braun</surname><given-names>T</given-names></name></person-group><article-title>A role for Fgf-6 in skeletal muscle regeneration.</article-title><source>Genes Dev</source><year>1997</year><volume>11</volume><fpage>2040</fpage><lpage>2051</lpage><comment>Mice lacking <italic>Fgf6</italic> show a severe muscle regeneration defect with fibrosis and myotube degeneration.</comment><pub-id pub-id-type="pmid">9284044</pub-id></citation></ref><ref id="B119"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fiore</surname><given-names>F</given-names></name><name><surname>Planche</surname><given-names>J</given-names></name><name><surname>Gibier</surname><given-names>P</given-names></name><name><surname>Sebille</surname><given-names>A</given-names></name><name><surname>Delapeyriere</surname><given-names>O</given-names></name><name><surname>Birnbaum</surname><given-names>D</given-names></name></person-group><article-title>Apparent normal phenotype of Fgf6-/- mice.</article-title><source>Int J Dev Biol</source><year>1997</year><volume>41</volume><fpage>639</fpage><lpage>642</lpage><comment>Mice lacking <italic>Fgf6</italic> are phenotypically normal.</comment><pub-id pub-id-type="pmid">9303352</pub-id></citation></ref><ref id="B120"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Degenstein</surname><given-names>L</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name></person-group><article-title>Keratinocyte growth factor is required for hair development but not for wound healing.</article-title><source>Genes Dev</source><year>1996</year><volume>10</volume><fpage>165</fpage><lpage>175</lpage><comment>Mice lacking <italic>Fgf7</italic> have a unexpectedly subtle phenotype affecting hair growth.</comment><pub-id pub-id-type="pmid">8566750</pub-id></citation></ref><ref id="B121"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>J</given-names></name><name><surname>Uzzo</surname><given-names>R</given-names></name><name><surname>Obara-Ishihara</surname><given-names>T</given-names></name><name><surname>Degenstein</surname><given-names>L</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name><name><surname>Herzlinger</surname><given-names>D</given-names></name></person-group><article-title>FGF-7 modulates ureteric bud growth and nephron number in the developing kidney.</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>547</fpage><lpage>554</lpage><comment>Identification of a second phenotype in mice lacking <italic>Fgf7</italic>. The developing ureteric bud and mature collecting system of <italic>Fgf7</italic>-null kidneys is markedly smaller than wild type and have 30% fewer nephrons than wild-type kidneys.</comment><pub-id pub-id-type="pmid">9876183</pub-id></citation></ref><ref id="B122"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Meyers</surname><given-names>EN</given-names></name><name><surname>Lewandoski</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><article-title>Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo.</article-title><source>Genes Dev</source><year>1999</year><volume>13</volume><fpage>1834</fpage><lpage>1846</lpage><comment>This study identifies <italic>Fgf8</italic> as a gene essential for gastrulation and shows that signaling via FGF8 and/or FGF4 is required for cell migration away from the primitive streak.</comment><pub-id pub-id-type="pmid">10421635</pub-id></citation></ref><ref id="B123"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shanmugalingam</surname><given-names>S</given-names></name><name><surname>Houart</surname><given-names>C</given-names></name><name><surname>Picker</surname><given-names>A</given-names></name><name><surname>Reifers</surname><given-names>F</given-names></name><name><surname>Macdonald</surname><given-names>R</given-names></name><name><surname>Barth</surname><given-names>A</given-names></name><name><surname>Griffin</surname><given-names>K</given-names></name><name><surname>Brand</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>SW</given-names></name></person-group><article-title>Ace/Fgf8 is required for forebrain commissure formation and patterning of the telencephalon.</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>2549</fpage><lpage>2561</lpage><comment>Demonstration that <italic>Fgf8/Ace</italic> is required for the development of midline structures in the zebrafish forebrain.</comment><pub-id pub-id-type="pmid">10821754</pub-id></citation></ref><ref id="B124"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Colvin</surname><given-names>JS</given-names></name><name><surname>Green</surname><given-names>RP</given-names></name><name><surname>Schmahl</surname><given-names>J</given-names></name><name><surname>Capel</surname><given-names>B</given-names></name><name><surname>Ornitz</surname><given-names>DM</given-names></name></person-group><article-title>Male to female sex reversal in mice lacking fibroblast growth factor 9.</article-title><source>Cell</source><year>2001</year><comment>This study demonstrates that FGF9 is essential for testicular mesenchymal growth, cord formation, and Sertoli and Leydig cell differentiation. FGF9 may also regulate mesonephric cell migration into the male gonad.</comment></citation></ref><ref id="B125"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohuchi</surname><given-names>H</given-names></name><name><surname>Hori</surname><given-names>Y</given-names></name><name><surname>Yamasaki</surname><given-names>M</given-names></name><name><surname>Harada</surname><given-names>H</given-names></name><name><surname>Sekine</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>S</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name></person-group><article-title>FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development.</article-title><source>Biochem Biophys Res Commun</source><year>2000</year><volume>277</volume><fpage>643</fpage><lpage>649</lpage><comment>Diverse phenotypes of mice lacking <italic>Fgf10</italic> closely resemble those of mice lacking <italic>FGFR2b</italic>. Major phenotypes include the absence of thyroid, pituitary, and salivary glands in addition to the previously described absence of limbs and lungs. Minor defects were observed in the formation of the teeth, kidneys, hair follicles, and digestive organs.</comment><pub-id pub-id-type="pmid">11062007</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.2000.3721</pub-id></citation></ref><ref id="B126"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Min</surname><given-names>H</given-names></name><name><surname>Danilenko</surname><given-names>DM</given-names></name><name><surname>Scully</surname><given-names>SA</given-names></name><name><surname>Bolon</surname><given-names>B</given-names></name><name><surname>Ring</surname><given-names>BD</given-names></name><name><surname>Tarpley</surname><given-names>JE</given-names></name><name><surname>DeRose</surname><given-names>M</given-names></name><name><surname>Simonet</surname><given-names>WS</given-names></name></person-group><article-title>Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to <italic>Drosophila</italic> branchless.</article-title><source>Genes Dev</source><year>1998</year><volume>12</volume><fpage>3156</fpage><lpage>3161</lpage><comment>Mice lacking <italic>Fgf10</italic> exhibited perinatal lethality associated with complete absence of lungs. <italic>Fgf10</italic> null mice also lack limbs. There is some disagreement with Sekine <italic>et al.</italic> [127] as to whether the apical ectodermal ridge transiently forms.</comment><pub-id pub-id-type="pmid">9784490</pub-id></citation></ref><ref id="B127"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname><given-names>K</given-names></name><name><surname>Ohuchi</surname><given-names>H</given-names></name><name><surname>Fujiwara</surname><given-names>M</given-names></name><name><surname>Yamasaki</surname><given-names>M</given-names></name><name><surname>Yoshizawa</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Yagishita</surname><given-names>N</given-names></name><name><surname>Matsui</surname><given-names>D</given-names></name><name><surname>Koga</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>N</given-names></name><name><surname>Kato</surname><given-names>S</given-names></name></person-group><article-title>Fgf10 is essential for limb and lung formation.</article-title><source>Nat Genet</source><year>1999</year><volume>21</volume><fpage>138</fpage><lpage>141</lpage><comment>Mice lacking <italic>Fgf10</italic> die at birth due to the lack of lung development beyond the trachea. Mice lacking <italic>Fgf10</italic> also had complete truncation of the forelmbs and hindlimbs. In <italic>Fgf10</italic> null embryos, limb bud formation was initiated but outgrowth of the limb buds did not occur.</comment><pub-id pub-id-type="pmid">9916808</pub-id><pub-id pub-id-type="doi">10.1038/5096</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p>Gene structure of selected members of the <italic>Fgf</italic> family. Only the portion of each gene containing coding exons is shown. Constitutively expressed exons are in black; alternatively spliced exons are in gray. <italic>Fgfs1, 2, 4</italic> and <italic>9</italic> contain the prototypic three-exon organization. For <italic>Fgf1</italic>, 5' untranslated exons are not shown; inclusion of these exons extends the gene by approximately 69 kb [<xref ref-type="bibr" rid="B78">78</xref>]. <italic>Fgf8</italic> is an example of a gene with 5' alternative splicing, and <italic>Fgf13</italic> demonstrates alternatively used 5' exons separated by over 30 kb. References: <italic>Fgf1</italic> [<xref ref-type="bibr" rid="B78">78</xref>]; <italic>Fgf2</italic> [<xref ref-type="bibr" rid="B79">79</xref>]; <italic>Fgf4</italic> [<xref ref-type="bibr" rid="B80">80</xref>]; <italic>Fgf8</italic> [<xref ref-type="bibr" rid="B52">52</xref>]; <italic>Fgf9</italic> [<xref ref-type="bibr" rid="B81">81</xref>]; <italic>Fgf13</italic> [<xref ref-type="bibr" rid="B76">76</xref>].</p></caption><graphic xlink:href="gb-2001-2-3-reviews3005-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p>Evolutionary relationships within the FGF family. <bold>(a)</bold> Apparent evolutionary relationships between FGFs from vertebrates, invertebrates and a virus. Amino-acid sequences of nine representative FGFs were chosen from human and compared with FGFs from <italic>Drosophila</italic>, <italic>C. elegans</italic>, zebrafish and <italic>Autographa californica</italic> nuclear polyhedrosis virus. <bold>(b)</bold> Apparent evolutionary relationships of the 22 known human and murine FGFs. Sequences were aligned using Genetyxsequence analysis software and trees were constructed from the alignments using the neighbor-joining method.</p></caption><graphic xlink:href="gb-2001-2-3-reviews3005-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>(a)</bold> Structural features of the FGF polypeptide. The amino terminus of some FGFs contains a signal sequence (shaded). All FGFs contain a core region that contains conserved amino-acid residues and conserved structural motifs. The locations of &#x003b2; strands within the core region are numbered and shown as black boxes. The heparin-binding region (pink) includes residues in the loop between &#x003b2; strands 1 and 2 and in &#x003b2; strands 10 and 11. Residues that contact the FGFR are shown in green (the region contacting Ig-domain 2 of the receptor), blue (contacting Ig-domain 3) and red (contacting the alternatively spliced region of Ig-domain 3). Amino-acid residues that contact the linker region are shown in gray [<xref ref-type="bibr" rid="B20">20</xref>]. <bold>(b)</bold> Three-dimensional structure of FGF2, a prototypical member of the FGF family. A ribbon diagram of FGF2 is shown; &#x003b2; strands are labeled 1-12 and regions of contact with the FGFR and heparin are color-coded as in (a) [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. Image provided by M. Mohammadi.</p></caption><graphic xlink:href="gb-2001-2-3-reviews3005-3"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Chromosomal localizations of FGFs in human and mouse</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center" colspan="2">Human</td><td align="center" colspan="2">Mouse</td><td align="center">References</td><td align="center" colspan="2">Accession numbers</td></tr><tr><td colspan="4"><hr></hr></td><td></td><td colspan="2"><hr></hr></td></tr><tr><td align="left">Gene</td><td align="center">Location</td><td align="center">Gene</td><td align="center">Location</td><td></td><td align="center">Human</td><td align="center">Mouse</td></tr></thead><tbody><tr><td align="left"><italic>FGF1</italic></td><td align="center">5q31</td><td align="center"><italic>Fgf</italic>1</td><td align="center">18</td><td align="center">[82,83]</td><td align="center">X65778, E03692, E04557</td><td align="center">U67610, M30641</td></tr><tr><td align="left"><italic>FGF2</italic></td><td align="center">4q26-27</td><td align="center"><italic>Fgf</italic>2</td><td align="center">3A2-B</td><td align="center">[84,85]</td><td align="center">E05628, M27968</td><td align="center">M30644, AF065903, AF065904, AF065905</td></tr><tr><td align="left"><italic>FGF3</italic></td><td align="center">11q13</td><td align="center"><italic>Fgf</italic>3</td><td align="center">7F</td><td align="center">[86,87,88]</td><td align="center">X14445</td><td align="center">Y00848</td></tr><tr><td align="left"><italic>FGF4</italic></td><td align="center">11q13.3</td><td align="center"><italic>Fgf</italic>4</td><td align="center">7F</td><td align="center">[87,89]</td><td align="center">E03343</td><td align="center">M30642</td></tr><tr><td align="left"><italic>FGF5</italic></td><td align="center">4q21</td><td align="center"><italic>Fgf</italic>5</td><td align="center">5E1-F</td><td align="center">[85,90]</td><td align="center">M37825</td><td align="center">M30643</td></tr><tr><td align="left"><italic>FGF6</italic></td><td align="center">12p13</td><td align="center"><italic>Fgf</italic>6</td><td align="center">6F3-G1</td><td align="center">[91,92]</td><td align="center">X63454</td><td align="center">M92416</td></tr><tr><td align="left"><italic>FGF7</italic></td><td align="center">15q15-21.1</td><td align="center"><italic>Fgf</italic>7</td><td align="center">2F-G</td><td align="center">[93,94]</td><td align="center">M60828</td><td align="center">Z22703</td></tr><tr><td align="left"><italic>FGF8</italic></td><td align="center">10q24</td><td align="center"><italic>Fgf</italic>8</td><td align="center">19C3-D</td><td align="center">[54,95]</td><td align="center">U36223, U56978</td><td align="center">Z48746</td></tr><tr><td align="left"><italic>FGF9</italic></td><td align="center">13q11-q12</td><td align="center"><italic>Fgf</italic>9</td><td align="center">14D</td><td align="center">[81,96,97]</td><td align="center">D14838</td><td align="center">U33535, D38258</td></tr><tr><td align="left"><italic>FGF10</italic></td><td align="center">5p12-p13</td><td align="center"><italic>Fgf</italic>10</td><td align="center">13A3-A4</td><td align="center">[98,99]</td><td align="center">AB002097</td><td align="center">D89080</td></tr><tr><td align="left"><italic>FGF11</italic></td><td align="center">17p13.1</td><td align="center"><italic>Fgf</italic>11</td><td align="center">-</td><td align="center">[100]</td><td align="center">U66199</td><td align="center">U66203</td></tr><tr><td align="left"><italic>(FHF3)</italic></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left"><italic>FGF12</italic></td><td align="center">3q28</td><td align="center"><italic>Fgf</italic>12</td><td align="center">16B1-B3</td><td align="center">[31,100,101,102]</td><td align="center">U66197</td><td align="center">U66201</td></tr><tr><td align="left"><italic>(FHF1)</italic></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left"><italic>FGF13</italic></td><td align="center">Xq26</td><td align="center"><italic>Fgf</italic>13</td><td align="center">X</td><td align="center">[31,76,103]</td><td align="center">U66198</td><td align="center">U66202, AF020737</td></tr><tr><td align="left"><italic>(FHF2)</italic></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left"><italic>FGF14</italic></td><td align="center">13q34</td><td align="center"><italic>Fgf</italic>14</td><td align="center">14</td><td align="center">[31]</td><td align="center">U66200</td><td align="center">U66204</td></tr><tr><td align="left"><italic>(FHF4)</italic></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">-</td><td></td><td align="center"><italic>Fgf</italic>15<sup>*</sup></td><td align="center">7F</td><td align="center">(N.I., unpublished observations)</td><td></td><td align="center">AF007268</td></tr><tr><td align="left"><italic>FGF16</italic></td><td align="center">-</td><td align="center"><italic>Fgf</italic>16</td><td align="center">-</td><td></td><td align="center">AB009391</td><td align="center">AB049219</td></tr><tr><td align="left"><italic>FGF17</italic></td><td align="center">8p21</td><td align="center"><italic>Fgf</italic>17</td><td align="center">14</td><td align="center">[104]</td><td align="center">AB009249</td><td align="center">AB009250</td></tr><tr><td align="left"><italic>FGF18</italic></td><td align="center">5q34</td><td align="center"><italic>Fgf</italic>18</td><td align="center">-</td><td align="center">[105]</td><td align="center">AB007422, AF075292</td><td align="center">AB004639, AF075291</td></tr><tr><td align="left"><italic>FGF19<sup>*</sup></italic></td><td align="center">11q13.1</td><td align="center">-</td><td></td><td align="center">[106]</td><td align="center">AB018122, AF110400</td><td></td></tr><tr><td align="left"><italic>FGF20</italic></td><td align="center">8p21.3-p22</td><td align="center"><italic>Fgf</italic>20</td><td align="center">-</td><td align="center">[27,107]</td><td align="center">AB030648, AB044277</td><td align="center">AB049218</td></tr><tr><td align="left"><italic>FGF21</italic></td><td align="center">19q13.1-qter</td><td align="center"><italic>Fgf</italic>21</td><td align="center">-</td><td align="center">[108]</td><td align="center">AB021975</td><td align="center">AB025718</td></tr><tr><td align="left"><italic>FGF22</italic></td><td align="center">19p13.3</td><td align="center"><italic>Fgf</italic>22</td><td align="center">-</td><td align="center">[109]</td><td align="center">AB021925</td><td align="center">AB036765</td></tr><tr><td align="left"><italic>FGF23</italic></td><td align="center">12p13.3</td><td align="center"><italic>Fgf</italic>23</td><td align="center">6F3-G1</td><td align="center">[7,75] (N.I., unpublished)</td><td align="center">AB037973, AF263537</td><td align="center">AB037889, AF263536</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup>Human <italic>FGF19</italic> and mouse <italic>Fgf15</italic> may be orthologous genes.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>FGF knockout mice</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Gene</td><td align="left">Survival of null mutant<sup>*</sup></td><td align="left">Phenotype</td><td align="left">References</td></tr></thead><tbody><tr><td align="left"><italic>Fgf1</italic></td><td align="left">Viable</td><td align="left">None identified</td><td align="left">[110]</td></tr><tr><td align="left"><italic>Fgf</italic>2</td><td align="left">Viable</td><td align="left">Mild cardiovascular, skeletal, neuronal</td><td align="left">[110,111,112,113,114]</td></tr><tr><td align="left"><italic>Fgf</italic>3</td><td align="left">Viable</td><td align="left">Mild inner ear, skeletal (tail)</td><td align="left">[115]</td></tr><tr><td align="left"><italic>Fgf</italic>4</td><td align="left">Lethal, E4-5</td><td align="left">Inner cell mass proliferation</td><td align="left">[116]</td></tr><tr><td align="left"><italic>Fgf</italic>5</td><td align="left">Viable</td><td align="left">Long hair, angora mutation</td><td align="left">[72]</td></tr><tr><td align="left"><italic>Fgf</italic>6</td><td align="left">Viable</td><td align="left">Subtle, muscle regeneration</td><td align="left">[117,118,119]</td></tr><tr><td align="left"><italic>Fgf</italic>7</td><td align="left">Viable</td><td align="left">Hair follicle growth, ureteric bud growth</td><td align="left">[120,121]</td></tr><tr><td align="left"><italic>Fgf</italic>8</td><td align="left">Lethal, E7</td><td align="left">Gastrulation defect, CNS development, limb development</td><td align="left">[67,70,122,123]</td></tr><tr><td align="left"><italic>Fgf</italic>9</td><td align="left">Lethal, P0</td><td align="left">Lung mesenchyme, XY sex reversal</td><td align="left">[124]; (J.S. Colvin <italic>et al</italic>., personal communication)</td></tr><tr><td align="left"><italic>Fgf</italic>10</td><td align="left">Lethal, P0</td><td align="left">Development of multiple organs, including limb, lung, thymus, pituitary</td><td align="left">[125,126,127]</td></tr><tr><td align="left"><italic>Fgf12 (Fhf1)</italic></td><td align="left">Viable</td><td align="left">Neuromuscular phenotype</td><td align="left">(J. Schoorlemmer and M. Goldfarb, personal communication)</td></tr><tr><td align="left"><italic>Fgf14 (Fhf4)</italic></td><td align="left">Viable</td><td align="left">Neurological phenotypes</td><td align="left">(Q. Wang, personal communication)</td></tr><tr><td align="left"><italic>Fgf15</italic></td><td align="left">Lethal, E9.5</td><td align="left">Not clear</td><td align="left">(J.R. McWhirter, personal communication)</td></tr><tr><td align="left"><italic>Fgf</italic>17</td><td align="left">Viable</td><td align="left">Cerebellar development</td><td align="left">[17]</td></tr><tr><td align="left"><italic>Fgf18</italic></td><td align="left">Lethal, P0</td><td align="left">Skeletal development</td><td align="left">(N. Ohbayashi, Z. Liu, personal communication)</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup>E, embryonic day; P, postnatal day.</p></table-wrap-foot></table-wrap></sec></back></article> 